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Desaturases and process for the production of polyunsaturated fatty acids in transgenic
organisms
Description
The present invention relates to polynucleotides from Cochliobolus heterostrophus C5,
Cyanothece sp. CCY0110, Mycocentrospora acerina and Hyaloperonospora parasitica,
which code for desaturases and which can be employed for the recombinant
production of polyunsaturated fatty acids. The invention furthermore relates to vectors,
host cells and transgenic nonhuman organisms which comprise the polynucleotides
according to the invention, and to the polypeptides encoded by the polynucleotides.
The invention furthermore relates to antibodies against the polypeptides according to
the invention. Finally, the invention also relates to production processes for the
polyunsaturated fatty acids and for oil, lipid and fatty acid compositions and to their use
as drugs, cosmetics, foodstuffs, feedstuffs, preferably fish food, or food supplements.
Fatty acids and triacylglycerides have a multiplicity of applications in the food industry,
in animal nutrition, in cosmetics and in the pharmacological sector. Depending on
whether they are free saturated or unsaturated fatty acids or else triacylglycerides with
an elevated content of saturated or unsaturated fatty acids, they are suitable for very
different applications. Polyunsaturated fatty acids such as linoleic acid and linolenic
acid are essential for mammals, since they cannot be produced by the latter
themselves. Polyunsaturated ω3-fatty acids and ω6-fatty acids are therefore an
important constituent in animal and human nutrition.
Polyunsaturated long-chain ω3-fatty acids such as eicosapentaenoic acid (= EPA,
C20:5∆5'8'1 1'14 '17) or docosahexaenoic acid (= DHA, C22:6∆4 7 10 13 16 19) are important
components in human nutrition owing to their various roles in health aspects, including
the development of the child brain, the functionality of the eyes, the synthesis of
hormones and other signal substances, and the prevention of cardiovascular disorders,
cancer and diabetes (Poulos, A Lipids 30:1-14, 1995; Horrocks, LA and Yeo YK
Pharmacol Res 40:21 1-225, 1999). This is why there is a demand for the production of
polyunsaturated long-chain fatty acids.
ω3-fatty acids, which are preferentially found in fish oils, to the food is particularly
important. Thus, for example, polyunsaturated fatty acids such as docosahexaenoic
acid (= DHA, C22:6∆4 7 10 13 16 19) or eicosapentaenoic acid (= EPA, C20:5∆5 1 4 7) are
added to infant formula to improve the nutritional value. The unsaturated fatty acid
DHA is said to have a positive effect on the development and maintenance of brain
functions.
Hereinbelow, polyunsaturated fatty acids are referred to as PUFA, PUFAs, LCPUFA or
LCPUFAs (polyunsaturated fatty acids, PUFA, long-chain polyunsaturated fatty acids,
LCPUFA) .
The various fatty acids and triglycerides are mainly obtained from microorganisms such
as Mortierella and Schizochytrium or from oil-producing plants such as soybean,
oilseed rape, algae such as Crypthecodinium or Phaeodactylum and other organisms,
where they are obtained, as a rule, in the form of their triacylglycerides (= triglycerides
= triglycerols). However, they can also be obtained from animals, such as, for example,
fish. The free fatty acids are advantageously prepared by hydrolysis. Very long-chain
polyunsaturated fatty acids such as DHA, EPA, arachidonic acid (= ARA,
C20:4∆5'8'1 1 4) , dihomo-γ-linolenic acid (C20:3∆8 1M ) or docosapentaenoic acid (DPA,
C22:5∆7'10'13 '16'19) are not synthesized in oil crops such as oilseed rape, soybean,
sunflower or safflower. Conventional natural sources of these fatty acids are fish such
as herring, salmon, sardine, redfish, eel, carp, trout, halibut, mackerel, zander or tuna,
or algae.
Depending on the intended use, oils with saturated or unsaturated fatty acids are
preferred. In human nutrition, for example, lipids with unsaturated fatty acids,
specifically polyunsaturated fatty acids, are preferred. The polyunsaturated ω3-fatty
acids are said to have a positive effect on the cholesterol level in the blood and thus on
the possibility of preventing heart disease. The risk of heart disease, a stroke or
hypertension can be reduced markedly by adding these ω3-fatty acids to food. Also,
ω3-fatty acids have a positive effect on inflammatory, specifically on chronically
inflammatory, processes in association with immunological diseases such as
rheumatoid arthritis. They are therefore added to foodstuffs, specifically to dietetic
foodstuffs, or are employed in medicaments. ω6-Fatty acids such as arachidonic acid
tend to have a negative effect on these disorders in connection with these rheumatic
diseases on account of our usual dietary intake.
ω3- and ω6-fatty acids are precursors of tissue hormones, known as eicosanoids, such
as the prostaglandins, which are derived from dihomo-γ-linolenic acid, arachidonic acid
and eicosapentaenoic acid, and of the thromboxanes and leukotrienes, which are
derived from arachidonic acid and eicosapentaenoic acid. Eicosanoids which are
formed from ω6-fatty acids (known as the PG2 series) generally promote inflammatory
reactions, while eicosanoids from ω3-fatty acids (known as the PG3 series) have little
or no proinflammatory effect.
Owing to their positive characteristics, there has been no lack of attempts in the past to
make available genes which are involved in the synthesis of fatty acids or triglycerides
for the production of oils in various organisms with a modified content of unsaturated
fatty acids. Thus, WO 91/1 3972 and its US equivalent describe a ∆9-desaturase.
WO 93/1 1245 claims a ∆ 15-desaturase and WO 94/1 15 16 a ∆ 12-desaturase. Further
desaturases are described, for example, in EP-A-O 550 162, WO 94/18337, WO
97/30582, WO 97/21 340, WO 95/1 8222, EP-A-O 794 250, Stukey et al., J. Biol.
Chem., 265, 1990: 20144-20149, Wada et al., Nature 347, 1990: 200-203 or Huang et
al., Lipids 34, 1999: 649-659. However, the biochemical characterization of the various
desaturases has been insufficient to date since the enzymes, being membrane-bound
proteins, present great difficulty in their isolation and characterization (McKeon et al.,
Methods in Enzymol. 7 1, 1981 : 12141-12147, Wang et al., Plant Physiol. Biochem.,
26, 1988: 777-792). As a rule, membrane-bound desaturases are characterized by
being introduced into a suitable organism which is subsequently analyzed for enzyme
activity by analyzing the starting materials and the products. ∆6-Desaturases are
described in W O 93/06712, US 5,614,393, WO 96/21022, WO 00/21557 and
WO 99/271 11. Their application for production in transgenic organisms is described, for
example, in WO 98/46763, WO 98/46764 and WO 98/46765. In this context, the
expression of various desaturases and the formation of polyunsaturated fatty acids is
also described and claimed; see, for example, WO 99/64616 or WO 98/46776. As
regards the expression efficacy of desaturases and its effect on the formation of
polyunsaturated fatty acids, it must be noted that the expression of a single desaturase
as described to date has only resulted in low contents of unsaturated fatty acids/lipids
such as, for example, γ-linolenic acid and stearidonic acid. Moreover, a mixture of ω3-
and ω6-fatty acids was obtained, as a rule.
Especially suitable microorganisms for the production of PUFAs are microalgae such
as Phaeodactylum tricornutum, Porphiridium species, Thraustochytrium species,
Schizochytrium species or Crypthecodinium species, ciliates such as Stylonychia or
Colpidium, fungae such as Mortierella, Entomophthora or Mucor and/or mosses such
as Physcomitrella, preferably Physcomitrella patens, Ceratodon and Marchantia (R.
Vazhappilly & F. Chen (1998) Botanica Marina 4 1: 553-558; K. Totani & K. Oba (1987)
Lipids 22: 1060-1062; M. Akimoto et al. (1998) Appl. Biochemistry and Biotechnology
73: 269-278). Strain selection has resulted in the development of a number of mutant
strains of the microorganisms in question which produce a series of desirable
compounds including PUFAs. However, the mutation and selection of strains with an
improved production of a particular molecule such as the polyunsaturated fatty acids is
a time-consuming and difficult process. This is why recombinant methods as described
above are preferred whenever possible. However, only limited amounts of the desired
polyunsaturated fatty acids such as DPA, EPA or ARA can be produced with the aid of
the abovementioned microorganisms. Moreover, depending on the microorganism
used, these are generally generated as fatty acid mixtures of, for example, EPA, DPA
and ARA.
A variety of synthetic pathways is being discussed for the synthesis of arachidonic acid,
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Thus, EPA or DHA are
produced in marine bacteria such as Vibrio sp. or Shewanella sp. via the polyketide
pathway (Yu, R. et al. Lipids 35:1061-1064, 2000; Takeyama, H. et al. Microbiology
143:2725-2731 , 1997).
An alternative strategy is the alternating activity of desaturases and elongases (Zank,
T.K. et al. Plant Journal 3 1 :255-268, 2002; Sakuradani, E. et al. Gene 238:445-453,
1999). A modification of the pathway described in Zank et al. and in Sakuradani et al.
via ∆6-desaturase, ∆6-elongase, ∆5-desaturase, ∆5-elongase and ∆4-desaturase is the
Sprecher synthesis pathway (Sprecher 2000, Biochim. Biophys. Acta 1486:219-231) in
mammals. Instead of the ∆4-desaturation, a further elongation step is effected here to
give C24, followed by a further ∆6-desaturation and finally β-oxidation to give the C22
chain length. What is known as the Sprecher synthesis pathway is, however, not
suitable for the production in plants and microorganisms since the regulatory
mechanisms are not yet known.
Depending on their desaturation pattern, the polyunsaturated fatty acids can be divided
into two large classes, viz. ω6- or ω3-fatty acids, which differ with regard to their
metabolic and functional activities. The starting material for the ω6-metabolic pathway
is the fatty acid linoleic acid (18:2 ∆9 2) , while the ω3-pathway proceeds via linolenic
acid (18:3 ∆9'12 '15) . Linolenic acid is formed by the activity of a ∆15-desaturase (Tocher
et al. 1998, Prog. Lipid Res. 37, 73-1 17; Domergue et al. 2002, Eur. J . Biochem. 269,
4105-41 13).
Mammals, and thus also humans, have no corresponding desaturase activity (∆ 12- and
∆15-desaturase) and must take up these fatty acids (essential fatty acids) via food.
Starting with these precursors, the physiologically important polyunsaturated fatty acids
arachidonic acid (= ARA, 20:4 ∆5'8'1 1 '14) , an ω6-fatty acid, and the two ω3-fatty acids
eicosapentaenoic acid (= EPA, 20:5 ∆5'8 1 '14 '17) and docosahexaenoic acid (DHA,
22:6 ∆4'7'10 '13'17 '19) are synthesized via the sequence of desaturase and elongase
reactions. The application of ω3-fatty acids shows the therapeutic activity described
above in the treatment of cardiovascular diseases (Shimikawa 2001 , World Rev. Nutr.
Diet. 88, 100-108), inflammations (Calder 2002, Proc. Nutr. Soc. 6 1 , 345-358) and
arthritis (Cleland and James 2000, J. Rheumatol. 27, 2305-2307).
Higher plants comprise polyunsaturated fatty acids such as linoleic acid (C18:2) and
linolenic acid (C18:3). ARA, EPA and DHA are not found at all in the seed oil of higher
plants, or only in miniscule amounts (E. Ucciani: Nouveau Dictionnaire des Huiles
Vegetales [New Dictionary of Vegetable Oils]. Technique & Documentation - Lavoisier,
1995. ISBN: 2-7430-0009-0). However, the production of LCPUFAs in higher plants
(preferably in oil crops such as oilseed rape, linseed, sunflower and soybeans) would
be advantageous since large amounts of high-quality LCPUFAs for the food industry,
animal nutrition and pharmaceutical purposes might be obtained economically. A
potential route is via recombinant methods, where genes which code for enzymes of
the biosynthesis of LCPUFAs are introduced and expressed into oil crops. These
genes code for, for example, ∆6-desaturases, ∆6-elongases, ∆5-desaturases or ∆4-
desaturases. These genes can advantageously be isolated from microorganisms and
lower plants which produce LCPUFAs and incorporate them in the membranes or
triacylglycerides. Thus, it has already been possible to isolate ∆6-desaturase genes
from the moss Physcomitrella patens and ∆6-elongase genes from P. patens and from
the nematode C. elegans. (Zank, T.K. et al. Plant Journal 3 1:255-268, 2002, Beaudoin
et al. Biochem Soc Trans 28 :661 -663, 2000).
The first transgenic plants which comprise and express genes coding for LCPUFA
biosynthesis enzymes and which produce LCPUFAs were described for example, in
DE-A-102 19 203 (process for the production of polyunsaturated fatty acids in plants).
However, these plants produce LCPU FAs in amounts which require further
optimization for processing the oils which are present in the plants.
To ensure the enrichment of food and of feed with these polyunsaturated fatty acids,
there is therefore a great need for means and measures for a simple, inexpensive
process for the production of these polyunsaturated fatty acids, specifically in
eukaryotic systems.
The object on which the present invention is based is the provision of such means and
measures. This object is achieved by the embodiments which are described in the
patent claims and hereinbelow.
The present invention thus relates to a polynucleotide comprising a nucleic acid
sequence selected from the group consisting of:
(a) nucleic acid sequence as shown in any of SEQ ID No. 1, 2 , 8 , 9 , 15, 16, 50 or 5 1;
(b) nucleic acid sequence which codes for a polypeptide which features an amino
acid sequence as shown in any of SEQ ID No. 3 , 10, 17 or 52;
(c) nucleic acid sequence which has at least 70% identity to one of the nucleic acid
sequences of (a) or (b), and which codes for a polypeptide with a desaturase
activity; and
(d) nucleic acid sequence for a fragment of a nucleic acid of (a), (b) or (c), wherein
the fragment codes for a polypeptide with a desaturase activity.
The class of the ω6-fatty acids is based on the ω6-fatty acid linoleic acid (18:2∆9,12),
while the class of the ω3-fatty acids is based on the (3-fatty acid linolenic acid
(18:3(9,12,15); see Figure 1. These two fatty acids are the substrates for the synthesis
of long-chain (6- and (3-PUFAs, respectively. The increase of the content in these fatty
acids according to the genes which are introduced leads to an increase of the content
in long-chain-PUFAs.
The present invention provides polynucleotide sequences which lead to an increase of
the substrates 18:2(9,12 and 18:3(9,12,15, respectively. There have been identified
polynucleotide sequences which code for enzymes with (12-desaturase activity, with
(12- and (15-desaturase activity, with (15-desaturase activity or with (3-desaturase
activity.
According to the invention, the term "polynucleotide" refers to polynucleotides which
comprise nucleic acid sequences which code for polypeptides with desaturase activity.
The desaturase activities are preferably required for the biosynthesis of lipids or fatty
acids. Especially preferably, they take the form of the following desaturase activities:
∆ 12-desaturase, ∆ 15-desaturase, ∆ 12- and ∆ 15-desaturase or omega-3-desaturase
activity. The desaturases are preferably involved in the synthesis of polyunsaturated
fatty acids (PUFAs) and especially preferably in the synthesis of long-chain PUFAs
(LCPUFAs). Suitable detection systems for these desaturase activities are described in
the examples or in WO 2005/083053. The desaturase activities according to the
invention especially preferably have substrate specificities and/or conversion rates
which are comparable to those of the respective homologous desaturase enzymes
from Pythium irregulare, Ostreococcus tauri, Phytophtora sojae or Phytophtora
infestans. The specific polynucleotides according to the invention, i.e. the
polynucleotides with a nucleic acid sequence as shown in SEQ ID No.: 1, 2 , 8 , 9 , 15 ,
16, 50 or 5 1 have been obtained from Cochliobolus heterostrophus C5, Cyanothece
sp. CCY01 10 , Polaromonas sp. JS666, Prochlorococcus marinus str. MIT 931 3 ,
Synechococcus sp. PCC 7335, Mycocentrospora acerina or Hyaloperonospora
parasitica.
In particular, the nucleic acid sequences according to SEQ ID No. 1 and 2 originate
from Cochliobolus heterostrophus C5, the nucleic acid sequences according to SEQ ID
No. 8 and 9 from Cyanothece sp. CCY0110, the nucleic acid sequences according to
SEQ ID No. 15 and 16 from Mycocentrospora acerina and the nucleic acid sequences
according to SEQ ID No. 50 and 5 1 from Hyaloperonospora parasitica. SEQ ID No. 1,
8 and 50 are genomic sequences, SEQ ID No. 15 is an mRNA transcript, while SEQ ID
No. 2 , 9 , 16 and 5 1 are coding sequences (cds). SEQ ID No. 3 , 10, 17 and 52 show the
corresponding amino acid sequences.
Thus, polynucleotides according to the invention are especially preferred:
Polynucleotides which code for a polypeptide with ∆ 15-desaturase activity and which
comprise (i) a nucleic acid sequence as shown in SEQ ID No. 1 or 2 , (ii) a nucleic acid
sequence which codes for a polypeptide as shown in SEQ ID No. 3 , (iii) a nucleic acid
sequence which has at least 70% identity to one of the nucleic acid sequences of (i) or
(ii), or (iv) a nucleic acid sequence for a fragment of a nucleic acid of (i), (ii) or (iii),
where the fragment codes for a polypeptide with a ∆ 15-desaturase activity.
Polynucleotides which code for a polypeptide with ∆ 15-desaturase activity and which
comprise (i) a nucleic acid sequence as shown in SEQ ID No. 8 or 9 , (ii) a nucleic acid
sequence which codes for a polypeptide as shown in SEQ ID No. 10, (iii) a nucleic acid
sequence which has at least 70% identity to one of the nucleic acid sequences of (i) or
(ii), or (iv) a nucleic acid sequence for a fragment of a nucleic acid of (i), (ii) or (iii),
where the fragment codes for a polypeptide with a ∆ 15-desaturase activity.
Polynucleotides which code for a polypeptide with ∆ 12-desaturase activity and which
comprise (i) a nucleic acid sequence as shown in SEQ ID No. 15 or 16, (ii) a nucleic
acid sequence which codes for a polypeptide as shown in SEQ ID No. 17, (iii) a nucleic
acid sequence which has at least 70% identity to one of the nucleic acid sequences of
(i) or (ii), or (iv) a nucleic acid sequence for a fragment of a nucleic acid of (i), (ii) or (iii),
where the fragment codes for a polypeptide with a ∆ 12-desaturase activity.
Polynucleotides which code for a polypeptide with ω3-desaturase activity and which
comprise (i) a nucleic acid sequence as shown in SEQ ID No. 50 or 5 1 , (ii) a nucleic
acid sequence which codes for a polypeptide as shown in SEQ ID No. 52, (iii) a nucleic
acid sequence which has at least 70% identity to one of the nucleic acid sequences of
(i) or (ii), or (iv) a nucleic acid sequence for a fragment of a nucleic acid of (i), (ii) or (iii),
where the fragment codes for a polypeptide with a ω3-desaturase activity.
The term "delta-12-desaturase (or ∆-12-desaturase or d-12-desaturase or d12-Des or
d12Des)" or "delta-12-desaturase (or ∆-12-desaturase or d-12-desaturase or d12-Des
or d12Des) activity" as used in the present context refers to an enzyme with the
enzymatic function for dehydrogenating C18-fatty acids which are already
dehydrogenated on the C atom 9-10. Here, the C atoms C12 and C13 are
dehydrogenated in each case one hydrogen atom, giving rise to a double bond
between these two C atoms.
The term "delta-15-desaturase (or ∆-15-desaturase or d-15-desaturase or d15-Des or
d15Des)" or "delta-15-desaturase (or ∆-15-desaturase or d-15-desaturase or d15-Des
or d 15Des) activity" as used in the present context refers to an enzyme with the
enzymatic function for dehydrogenating C 18- and/or C20-fatty acids which are
dehydrogenated on the C atoms 6-7, 8-9, 9-10, 12-13 and/or 13-14. Here, the C atoms
C15-16 and/or C 17-18 are dehydrogenated in each case one hydrogen atom, giving
rise to a double bond between the two C atoms.
The term "delta-12- and delta-15-desaturase (or ∆-12- and ∆-15-desaturase or as
written hereinabove)" or "delta-12- and delta-15-desaturase (or ∆-12- and ∆-15-
desaturase or as written hereinabove) activity" as used in the present context refers to
an enzyme with the enzymatic function for dehydrogenating C18- and/or C20-fatty
acids which are dehydrogenated on the C atoms 6-7, 8-9, 9-10 and/or 13-14. Here, the
C atoms C12-1 3 and C15-16 and/or C17-18 are dehydrogenated in each case one
hydrogen atom, giving rise to a double bond between the two C atoms.
The term "omega-3-desaturase (or (3-desaturase or (3-Des or (3Des or omega3 Des or
o3Des) " or "omega-3-desaturase (or (3-desaturase or (3-Des or (3Des or omega3 Des
or o3Des) activity" as used in the present context refers to an enzyme with the
enzymatic function for the dehydrogenation of C18-, C20- and/or C22-fatty acids which
are dehydrogenated on the C atoms 4-5, 5-6, 6-7, 8-9, 9-10, 13-14 and/or 16-17. Here,
the C atoms C 15-16 and/or C 17-1 8 and/or C 19-20 are dehydrogenated by in each
case one hydrogen atom, giving rise to a double bond between the two C atoms.
Desaturases according to the invention especially preferably feature, in succession, the
desaturase motif 1 "GX10HX3HX13GX9PX3WX3H" (SEQ ID No. 46), the desaturase
motif 2 "PX1 4(H/Q)H " (SEQ ID No. 47) and either the desaturase motif 3
"HX2HHX5PXY" (SEQ ID No. 48) or the desaturase motif 4 "HX2HHX6PXY" (SEQ ID
No. 49), where X stands for any amino acid. Whether it is a ∆ 12-, ∆ 15- or omega3-
desaturase can be deduced from the amino acid at the variable position 16 of the
desaturase motif 2 (H or Q): Q = glutamine is indicative of putative ∆ 12-desaturases,
H = histidine is indicative of ∆ 15- or omega3-desaturases.
In this context, the polynucleotide sequences or the peptide sequences according to
the invention preferably originate from the abovementioned organisms.
It is clear that, in the light of the degeneracy of the genetic code, the abovementioned
specific sequences can also be modified, where the modified polynucleotides still code
for polypeptides with an amino acid sequence as shown in any of SEQ ID No. 3 , 10, 17
or 52 and which have the abovementioned desaturase activities.
The term "polynucleotide" also comprises variants of the abovementioned specific
polynucleotides. These may take the form of homologous, orthologous or paralogous
sequences. Such variants comprise nucleic acid sequences which feature at least one
base substitution, one base addition or one base deletion, it being intended that the
variants still code for a polypeptide with the abovementioned biological activity of the
respective starting sequence. Variants comprise polynucleotides which are capable of
hybridization with the abovementioned polynucleotides, preferably under stringent
conditions. Especially preferred stringent conditions are known to the skilled worker
and can be found in Current Protocols in Molecular Biology, John Wiley & Sons, N.Y.
(1989), 6.3.1-6.3.6. A preferred example of stringent hybridization conditions are
hybridizations in 6 x sodium chloride/sodium citrate (= SSC) at approximately 45°C,
preferably 500C, 55°C, 600C and most preferably at 62°C, followed by one or more
wash steps in 0.1 x SSC, 0.1 % SDS at 50 to 65°C, preferably 55 to 65°C even more
preferably at 60 to 65°C. The skilled worker knows that these hybridization conditions
differ as a function of the type of nucleic acid and, for example when organic solvents
are present, with regard to the temperature and the buffer concentration. Under
"standard hybridization conditions", the temperature differs as a function of the type of
nucleic acid between 42°C and 58°C in aqueous buffer with a concentration of from 0.1
to 5 x SSC (pH 7.2). If organic solvent is present in the abovementioned buffer, for
example 50% formamide, the temperature under standard conditions is approximately
42°C. The hybridization conditions for DNA:DNA hybrids are preferably for example 0.1
x SSC and 200C to 45°C, preferably between 300C and 45°C. The hybridization
conditions for DNA:RNA hybrids are preferably for example 0.1 x SSC and 300C to
55°C, preferably between 45°C and 55°C. The abovementioned hybridization
temperatures are determined for example for a nucleic acid of approximately 100 bp (=
base pairs) in length and a G + C content of 50% in the absence of formamide. The
skilled worker knows how to determine the hybridization conditions required with the
aid of textbooks, such as the one mentioned hereinabove, or from the following
textbooks: Sambrook et al., "Molecular Cloning", Cold Spring Harbor Laboratory, 1989;
Hames and Higgins (eds.) 1985, "Nucleic Acids Hybridization: A Practical Approach",
IRL Press at Oxford University Press, Oxford; Brown (ed.) 1991 , "Essential Molecular
Biology: A Practical Approach", IRL Press at Oxford University Press, Oxford. As an
alternative, variants of the specific polynucleotides according to the invention may also
be provided by polymerase chain reaction (PCR)-based methods. To this end, it is
possible first to derive primers from conserved sequences (for example sequences
which code for functional domains in the polypeptide). Conserved sequences can be
determined by sequence comparisons with polynucleotides which code for
polypeptides with a similar activity. The template used may be DNA or cDNA from
bacteria, fungi, plants or animals. DNA fragments obtained by PCR can be used for
screening suitable genomic libraries or cDNA libraries in order to - if required - isolate
the complete open reading frame of the polynucleotide and to determine it by
sequencing. Preferred variants comprise polynucleotides which comprise a nucleic acid
sequence with at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at
least 75%, at least 80%, at least 8 1%, at least 82%, at least 83%, at least 84%, at least
85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 9 1%,
at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at
least 98% or at least 99% (or a different percentage than mentioned herein) identity
with one of the abovementioned specific nucleic acid sequences and codes for a
polypeptide with the respective biological activity. Equally preferably comprised are
polynucleotides which comprise nucleic acid sequences which code for a polypeptide
with an amino acid sequence with at least 50%, at least 55%, at least 60%, at least
65%, at least 70%, at least 75%, at least 80%, at least 8 1%, at least 82%, at least 83%,
at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at
least 90%, at least 9 1%, at least 92%, at least 93%, at least 94%, at least 95%, at least
96%, at least 97%, at least 98% or at least 99% (or a different percentage than
mentioned herein) identity with one of the abovementioned specific amino acid
sequences and where the polypeptide has the respective biological activity of the
starting sequence.
The percentage of identical nucleotides or amino acids preferably relates to a
sequence segment of at least 50% of the sequences to be compared, and especially
preferably over the entire length of the sequences to be compared. A multiplicity of
programs which implement algorithms for such comparisons are described in the prior
art and commercially available. In particular, reference may be made to the algorithms
of Needleman and Wunsch or Smith and Waterman, which give particularly reliable
results. These algorithms can preferably be implemented by the following programs:
PiIeUp (J. MoI. Evolution., 25, 351-360, 1987, Higgins 1989, CABIOS, 5 : 151-153),
Gap and BestFit (Needleman and Wunsch (J. MoI. Biol. 48; 443-453 (1970) and Smith
and Waterman (Adv. Appl. Math. 2 ; 482-489(1981))), as part of the GCG software
(Genetics Computer Group, 575 Science Drive, Madison, Wisconsin, USA 5371 1,
1991). For the purposes of the present invention, it is especially preferred to determine
the percentage (%) of the sequence identity with the GAP program over the entire
sequence, with the following set parameters: Gap Weight: 50, Length Weight: 3 ,
Average Match: 10.000 and Average Mismatch: 0.000.
A polynucleotide which only comprises a fragment of the abovementioned nucleic acid
sequences is also a polynucleotide according to the invention. Here, it is intended that
the fragment codes for a polypeptide which features the biological activity of the
starting sequence, or of the polypeptide which the latter codes for. Polypeptides which
are encoded by such polynucleotides therefore comprise, or consist of, domains of the
abovementioned specific polypeptides (starting polypeptides) which confer the
biological activity. A fragment for the purposes of the invention preferably comprises at
least 50, at least 100, at least 250 or at least 500 consecutive nucleotides of the
abovementioned specific sequences or codes for an amino acid sequence comprising
at least 20, at least 30, at least 50, at least 80, at least 100 or at least 150 consecutive
amino acids of one of the abovementioned specific amino acid sequences, and confers
biological activity, preferably desaturase activity, as described above.
The polynucleotide variants according to the invention preferably feature at least 10%,
at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at
least 80% or at least 90% of the respective biological activity of the polypeptide which
is encoded by the starting sequence. That is to say the polypeptides which are
encoded by the polynucleotides according to the invention can participate in the
metabolism of compounds required for the synthesis of fatty acids, fatty acid esters
such as diacylglycerides and/or triacylglycerides in an organism, preferably in a plant or
plant cell, or can participate in the transport of molecules across membranes, which
means Ciβ- , C20- or C22-carbon chains in the fatty acid molecule with double bonds at at
least two, advantageously three, four, five or six positions.
The polynucleotides according to the invention either comprise the abovementioned
specific nucleic acid sequences o r consist of them. That is to say, that the
polynucleotides according to the invention may, in principle, also comprise further
nucleotides. These may preferably be 3 ' - or 5 ' -untranslated regions of the genomic
nucleic acid sequence. They preferably consist of at least 100, 200 or 500 nucleotides
at the 5' terminus and of at least 20, 50 or 100 nucleotides at the 3' terminus of the
coding region. Further polynucleotides which comprise additional nucleic acid
sequences are those which code for fusion proteins. Such fusion proteins can code for
further polypeptides or polypeptide portions, in addition to the abovementioned
polypeptides. The additional polypeptide or polypeptide portion may take the form of
further enzymes of lipid or fatty acid biosynthesis. Others which are feasible are
polypeptides which may act as expression markers (green, yellow, red, blue
fluorescent proteins, alkaline phosphatase and others) or so-called "tags" as labels or
as an aid for purification (for example FLAG tags, 6-histidine tags, MYC tags and
others).
Polynucleotide variants can be isolated from different natural or artificial sources. For
example, they can be generated artificially by in-vitro or in-vivo mutagenesis. Homologs
or orthologs of the specific sequences can be obtained from a wide range of animals,
plants and microorganisms. They are preferably obtained from algae. Algae such as
Isochrysis, Euglena or Crypthecodinium, algae/diatoms such as Thalassiosira,
Phaeodactylum or Thraustochytrium, Pythium, mosses such as Physcomitrella,
preferably Physcomitrella patens or Ceratodon are preferred, very especially preferred
are the algae of the genus Euglena or the diatoms of the class Oomycota such as the
genera Pythium or Phytophtora or fungi such as Postia placenta or Microdochium
nivale, or from the division Zygomycota from the genera Rhizopus, Aspergillus,
Thraustochytrium, Phytophthora, Entomophthora, Mucor or Mortierella. The
polynucleotides can also be obtained from plants, preferably from the family
Selaginellaceae, such as Selaginella moellendorffii, or from higher plants such as
Primulaceae such as Aleuritia, Calendula stellata, Osteospermum spinescens or
Osteospermum hyoseroides, bacteria such as Shewanella, cyanobacteria such as
Synechococcus, yeasts or animals such as nematodes, for example Caenorhabditis,
molluses, insects or fish. The polynucleotide variants are also preferably derived from
an animal from the order vertebrates. Especially preferably, the polynucleotides are
derived from the class Vertebrata; Euteleostomi, Actinopterygii; Neopterygii; Teleostei;
Euteleostei, Protacanthopterygii, Salmoniformes; Salmonidae or Oncorhynchus and,
very especially preferably, from the order Salmoniformes such as the family
Salmonidae, such as the genus Salmo, for example from the genera and species
Oncorhynchus mykiss, Trutta trutta or Salmo trutta fario. Here, the polynucleotides
according to the invention can be isolated by means of standard techniques of
molecular biology and of the sequence information provided herein. Also, it is possible,
with the aid of comparative algorithms, to identify for example a homologous sequence
or homologous, conserved sequence regions at the DNA or amino acid level. These
can be employed as hybridization probe and standard hybridization techniques (such
as, for example, those described in Sambrook et al., Molecular Cloning: A Laboratory
Manual. 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory
Press, Cold Spring Harbor, NY, 1989) for isolating further nucleic acid sequences
which are useful in the process. Moreover, it is possible to isolate polynucleotides or
fragments thereof by means of polymerase chain reaction (PCR), where
oligonucleotide primers which are based on this sequence or parts thereof are
employed (for example, a nucleic acid molecule comprising the complete sequence or
part thereof can be isolated by polymerase chain reaction using oligonucleotide primers
which have been generated on the basis of this same sequence). For example, it is
possible to isolate mRNA from cells (for example by the guanidinium thiocyanate
extractive method by Chirgwin et al. (1979) Biochemistry 18:5294-5299), and cDNA
can be generated by means of reverse transcriptase (for example Moloney MLV
reverse transcriptase, obtainable from Gibco/BRL, Bethesda, MD, or AMV reverse
transcriptase, obtainable from Seikagaku America, Inc., St. Petersburg, FL). Synthetic
oligonucleotide primers for the amplification by means of polymerase chain reaction
can be generated on the basis of the polynucleotide and amino acid sequences shown
in the SEQ ID numbers (SEQ ID NR:). A nucleic acid according to the invention can be
amplified using cDNA or, alternatively, genomic DNA as the template and suitable
oligonucleotide primers, following standard PCR amplification techniques. The nucleic
acid amplified thus can be cloned into a suitable vector and characterized by means of
DNA sequence analysis. Oligonucleotides which correspond to a desaturase
nucleotide sequence can be generated by standard synthetic methods, for example
using an automatic DNA synthesizer.
The polynucleotides according to the invention can either be provided in the form of
isolated polynucleotides (i.e. isolated from their natural origin, for example the genomic
locus) or else in genetically modified form (i.e. the polynucleotides may also be present
at their natural genetic locus, but, in such a case, must be genetically modified). An
isolated polynucleotide preferably comprises less than 5 kb, 4 kb, 3 kb, 2 kb, 1 kb,
0.5 kb or 0.1 kb of nucleic acid sequence which occurs naturally in its environment. The
polynucleotide according to the invention may be present as a single-stranded or
double-stranded nucleic acid molecule and may take the form of genomic DNA, cDNA
or RNA. Preferably, the polynucleotide according to the invention consists of RNA or
DNA. The polynucleotides according to the invention comprise all orientations of the
sequences shown in the SEQ ID numbers, i.e. also complementary strands and
reverse, or reverse-complementary, orientations. The term furthermore also comprises
chemically modified nucleic acids, such as the naturally occurring methylated DNA
molecules, or artificial nucleic acids, for example biotinylated nucleic acids.
The invention also comprises oligonucleotides of at least 15 bp, preferably at least
20 bp, at least 25 bp, at least 30 bp, at least 35 bp or at least 50 bp, which are capable
of specifically hybridizing under stringent conditions with one of the abovementioned
polynucleotides. The oligonucleotides may consist of DNA or RNA or both. Such
oligonucleotides can be employed as primers for the PCR, as expression-inhibitory
antisense oligonucleotides, for RNA interference (RNAi) approaches o r for
chimeroplastic or genoplastic approaches. RNAi methods are described for example in
Fire et al., Nature (1998) 391 :806-81 1; Fire, Trends Genet. 15, 358-363 (1999); Sharp,
RNA interference 2001 . Genes Dev. 15,485-490 (2001); Hammond et al. Nature Rev.
Genet. 2 , 1110-1 119 (2001 ) ; Tuschl, Chem. Biochem. 2 , 239-245 (2001 ) ; Hamilton et
al., Science 286, 950-952 ( 1999); Hammond et al., Nature 404, 293-296 (2000);
Zamore et al., Cell 10 1, 25-33 (2000); Bernstein et al., Nature 409, 363-366 (2001);
Elbashir et al., Genes Dev. 15 , 188-200 (2001 ) ; W O 01/29058; W O 99/3261 9 ; or
Elbashir et al., 2001 Nature 4 11: 494-498 and serve for inhibiting gene expression by
degrading the mRNA. Chimeroplastic or genoplastic approaches serve the in-vivo
modification (for example the introduction of point mutations) into genes at their
endogenous loci. Corresponding methods are disclosed in US5,565,350, US5,756,325,
US5,871 ,984, US5,731 ,181 , US5,795,972, US6,573,046, US6,21 1,351 , US6,586,184,
US6,271 ,360 and US6,479,292.
Advantageously, it has emerged that the polynucleotides according to the invention can
be employed particularly efficiently for the recombinant production of polyunsaturated
fatty acids in host cells and in transgenic organisms. In particular, the polypeptides
which are encoded by the polynucleotides according to the invention and which have
∆ 12-desaturase, ∆15-desaturase, ∆ 12- and ∆ 15-desaturase or omega-3-desaturase
activity are capable of converting Cis-, C20- and C22-fatty acids with one, two, three, four
or five double bonds and preferably polyunsaturated Cis-fatty acids with one, two or
three double bonds such as Ci8 : i (9, C18 :2 (9, 12 or ci8 :3 (6, 9, 12 ,
polyunsaturated C20-fatty acids with three or four double bonds
such a s C2 0 : 3 ( 8 , 1 1 , 1 4 , C2 0 : 4 (5 , 8 , 1 1 , 1 4 o r C2 0 : 4(8,1 1,14,17 or
polyunsaturated C22-fatty acids with four or five double bonds such as
C22:4(7,10,13,16 or C22:5(7,10,13,16,19. Especially preferably, the polynucleotide and
amino acid sequences according to the invention lead to an increase in the 18:2(9,12-
or 18:3(9,1 2 ,15-fatty acids. Figure 1 shows where these desaturases according to the
invention engage in the biosynthesis of long-chain polyunsaturated fatty acids and/or
how they can be used for producing these fatty acids.
In this context, it is especially preferred to employ the ∆6-desaturase encoded by the
polynucleotide sequence with SEQ ID No. 22 (dθDes(Pir)), the ∆6-elongase encoded
by the polynucleotide sequence with SEQ ID No. 3 1 (d6Elo(Pp)), the ∆5-desaturase
encoded by the polynucleotide sequence with SEQ ID No. 25 (d5Des(Tc)), the ∆15-
elongase encoded by the polynucleotide sequence with SEQ ID No. 34 (d5Des(Ot)),
the ∆14-desaturase encoded by the polynucleotide sequence with SEQ ID No. 37
(d4Des(Tc)), the ∆6-elongase encoded by the polynucleotide sequence with SEQ ID
No. 40 (d6Elo(Tp)), the ∆6-desaturase encoded by the polynucleotide sequence with
SEQ ID No. 4 1 (d6Des(Tc)) with one or more of the desaturases according to the
invention in order to synthesize long-chain polyunsaturated fatty acids; see in this
context WO2006/1 00241 . Alternatively, it was also possible to employ a ∆9-elongase
and a ∆8-desaturase instead of the abovementioned ∆6-desaturase and the ∆6-
elongase as described in WO2004/057001 . Depending on the fatty acid which is to be
prepared, it is possible to coexpress, in the host cells or transgenic organisms
described hereinbelow, or to use in the methods according to the invention, a variety of
combinations of the polynucleotides according to the invention with the
abovementioned desaturases or elongases. Especially preferred combinations for the
production of eicosapentaenoic acid are shown in tables 5 and 8 and for
docosahexaenoic acid in table 6 hereinbelow. For example, it is possible to use a ∆12-
desaturase, ∆15-desaturase, ∆12- and ∆15-desaturase, or omega-3-desaturase
according to the invention, alone or in a suitable combination (for example a ∆ 12-
desaturase and a ∆15-desaturase), together with dθDes(Pir) and/or d6Des(Ot),
d6Elo(Pp), d5Des(Tc) and ω3Des(Pi) for the production of EPA. Equally, a ∆12-
desaturase, ∆15-desaturase, ∆12- and ∆15-desaturase, or omega-3-desaturase
according to the invention, alone or in a suitable combination, can be used together
with d Des(Pir) and/or d6Des(Ot), d6Elo(Pp), d5Des(Tc), ω3Des(Pi), d5Elo(Ot),
d4Des(Tc) for the production of docosahexaenoic acid.
Preferably, it is the fatty acids in phospholipids or CoA fatty acid esters which are
desaturated, advantageously in the CoA fatty acid esters. Thus, a simple, inexpensive
production of these polyunsaturated fatty acids is possible, specifically in eukaryotic
systems. The unsaturated fatty acids produced by means of the polynucleotides
according to the invention can then be formulated as oil, lipid and fatty acid
compositions and can be employed in a suitable manner.
The present invention furthermore relates to a vector which comprises the
polynucleotide according to the invention.
The term "vector" refers to a nucleic acid molecule which is capable of transporting
another nucleic acid molecule, such as the polynucleotides according to the invention,
to which it is bound. One type of vector is a plasmid, a circular double-stranded DNA
loop into which additional DNA segments can be ligated. A further type of vector is a
viral vector, it being possible for additional DNA segments to be ligated into the viral
genome. Certain vectors are capable of autonomous replication in a host cell into
which they have been introduced (for example bacterial vectors with bacterial
replication origin). Other vectors are advantageously integrated into the genome of a
host cell when they are introduced into the host cell, and thus replicate together with
the host genome. Moreover, certain vectors can govern the expression of genes with
which they are in operable linkage. These vectors are referred to in the present context
as expression vectors. Usually, expression vectors which are suitable for DNA
recombination techniques take the form of plasmids. In the present description,
"plasmid" and "vector" can be used exchangeably since the plasmid is the form of
vector which is most frequently used. However, the invention is also intended to
comprise other forms of expression vectors, such as viral vectors, which exert similar
functions. Furthermore, the term "vector" is also intended to comprise other vectors
with which the skilled worker is familiar, such as phages, viruses such as SV40, CMV,
TMV, transposons, IS elements, phasmids, phagemids, cosmids, linear or circular
DNA, artificial chromosomes. Finally, the term also comprises constructs for the
targeted , i.e. homologous, recombination, or the heterologous insertion of
polynucleotides.
Vectors can be introduced into prokaryotic and eukaryotic cells via conventional
transformation or transfection techniques. The terms "transformation" and
"transfection", conjugation and transduction, as used in the present context, are
intended to comprise a multiplicity of methods known in the prior art for the introduction
of foreign nucleic acid (for example DNA) into a host cell, including calcium phosphate
or calcium chloride coprecipitation, DEAE-dextran-mediated transfection, lipofection,
natural competence, chemically mediated transfer, electroporation or particle
bombardment. Suitable methods for the transformation or transfection of host cells,
including plant cells, can be found in Sambrook et al. (Molecular Cloning: A Laboratory
Manual., 2nd ed., Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory
Press, Cold Spring Harbor, NY, 1989) and other laboratory textbooks such as Methods
in Molecular Biology, 1995, Vol. 44, Agrobacterium protocols, Ed.: Gartland and Davey,
Humana Press, Totowa, New Jersey.
Suitable cloning vectors are generally known to the skilled worker. In particular, they
include vectors which can replicate in microbial systems, that is mainly vectors which
ensure efficient cloning in yeasts or fungi and which make possible the stable
transformation of plants. Those which must be mentioned are in particular various
binary and cointegrated vector systems which are suitable for the T-DNA-mediated
transformation. Such vector systems are, as a rule, characterized in that they comprise
at least the vir genes, which are required for the agrobacterium-mediated
transformation, and the T-DNA-bordering sequences (T-DNA border). Preferably, these
vector systems also comprise further cis-regulatory regions such as promoters and
terminators and/or selection markers, by means of which suitably transformed
organisms can be identified. While in the case of cointegrated vector systems vir genes
and T-DNA sequences are arranged on the same vector, binary systems are based on
at least two vectors, one of which bears vir genes, but no T-DNA, and the other bears
T-DNA, but no vir gene. As a result, the last-mentioned vectors are relatively small,
easy to manipulate and to replicate both in E. coli and in Agrobacterium. These binary
vectors include vectors from the pBI B-HYG series, the pPZP series, the pBecks series
and the pGreen series. Preferably used according to the invention are Bin19, pB1 101 ,
pBinAR, pGPTV and pCAMBIA. An overview of binary vectors and their use is found in
Hellens et al, Trends in Plant Science (2000) 5 , 446-451 . The vectors with the inserted
polynucleotides according to the invention can be propagated stably under selective
conditions in microorganisms, in particular Escherichia coli and Agrobacterium
tumefaciens, and make possible a transfer of heterologous DNA into plants or
microorganisms. The polynucleotides according to the invention can be introduced into
organisms such as microorganisms or plants by means of the cloning vectors and thus
used for transforming plants. Vectors which are suitable for this purpose are published
in: Plant Molecular Biology and Biotechnology (CRC Press, Boca Raton, Florida),
chapter 6/7, p. 71-1 19 (1993); F.F. White, Vectors for Gene Transfer in Higher Plants;
in: Transgenic Plants, vol. 1, Engineering and Utilization, eds.: Kung and R. Wu,
Academic Press, 1993, 15-38; B. Jenes et al., Techniques for Gene Transfer, in:
Transgenic Plants, vol. 1, Engineering and Utilization, eds.: Kung and R. Wu,
Academic Press ( 1993), 128-143; Potrykus, Annu. Rev. Plant Physiol. Plant Molec.
Biol. 42 (1991), 205-225.
The vector is preferably an expression vector. The polynucleotide is present in the
expression vector according to the invention in operative (i.e. functional) linkage with
an expression control sequence. The expression control sequence together with the
polynucleotide and optionally further sequence elements of the vector is also referred
to as the expression cassette. The expression control sequence ensures that, after
transformation or transfection into a host cell, the polynucleotide can be expressed.
The expression control sequence to be used preferably comprises cis-regulatory
elements such as promoter and/or enhancer nucleic acid sequences, which are
recognized by the transcription machinery of the host cells. The term furthermore
comprises other expression control elements, for example polyadenylation signals and
RNA-stabilizing sequences. These regulatory sequences are described for example in
Goeddel: Gene Expression Technology: Methods in Enzymology 185, Academic Press,
San Diego, CA (1990) or see: Gruber and Crosby, in: Methods in Plant Molecular
Biology and Biotechnology, CRC Press, Boca Raton, Florida, eds.: Glick and
Thompson, chapter 7 , 89-108, including the literature cited therein. Expression control
sequences comprise those which govern the constitutive expression of a nucleotide
sequence in many types of host cells, and those which govern the direct expression of
the nucleotide sequence only in certain host cells under certain conditions. The skilled
worker knows that the design of the expression vector may depend on factors such as
the choice of the host cell to be transformed, the extent of the expression of the desired
protein and the like. The polynucleotides according to the invention may be present in
one or more copies in the expression cassette or in the expression vector according to
the invention (for example in the form of several expression cassettes). Here, the
regulatory sequences or factors can preferably have a positive effect on the gene
expression of the introduced genes, as described above, and thereby increase it. Thus,
it is possible to enhance the regulatory elements advantageously at the transcription
level by using strong transcription signals such as promoters and/or "enhancers".
Besides, it is also possible to enhance the translation, for example by improving the
mRNA stability. Further expression control sequences within the meaning of the
present invention are translation terminators at the 3' end of the polynucleotides to be
translated. An example which can be used here is the OCS1 terminator. As in the case
of the promoters, a different terminator sequence should be used for each
polynucleotide to be expressed.
Preferred expression control sequences or regulatory sequences are present in
promoters such as the cos, tac, trp, tet, trp-tet, Ipp, lac, Ipp-lac, laclq, T7, T5, T3, gal,
trc, ara, SP6, λ-PR or λ-PL promoters and are advantageously employed in Gram-
negative bacteria. Further advantageous regulatory sequences are, for example,
present in the Gram-positive promoters amy and SPO2, in the yeast or fungal
promoters ADC1 , MFa, AC, P-60, CYC1 , GAPDH, TEF, rp28, ADH or in the plant
promoters CaMV/35S [Franck et al., Cell 2 1 (1980) 285-294], PRP1 [Ward et al., Plant.
MoI. Biol. 22 ( 1993)], SSU, OCS, Iib4, usp, STLS1 , B33, nos or in the ubiquitin or
phaseolin promoter. Advantageous in this context are also inducible promoters, such
as the promoters described in EP-A-O 388 186 (benzenesulfonamide-inducible), Plant
J. 2 , 1992:397-404 (Gatz et al., tetracycline-inducible), EP-A-O 335 528 (abscisic acid-
inducible) or WO 93/21334 (ethanol- or cyclohexenol-inducible). Further suitable plant
promoters are the cytosolic FBPase promoter or the ST-LSI promoter of potato
(Stockhaus et al., EMBO J . 8 , 1989, 2445), the glycine max phosphoribosyl-
pyrophosphate amidotransferase promoter (Genbank Accession No. U87999) or the
node-specific promoter described in EP-A-O 249 676. Especially advantageous
promoters are promoters which make possible the expression in tissues which are
involved in the biosynthesis of fatty acids. Very especially advantageous are seed-
specific promoters, such as the USP promoter, but also other promoters such as the
LeB4, DC3, phaseolin or napin promoter. Further especially advantageous promoters
are seed-specific promoters which can be used for monocotyledonous or
dicotyledonous plants and which are described in US 5,608,152 (oilseed rape napin
promoter), WO 98/45461 (Arobidopsis oleosin promoter), US 5,504,200 (Phaseolus
vulgaris phaseolin promoter), WO 91/13980 (Brassica Bce4 promoter), by Baeumlein
et al., Plant J., 2 , 2 , 1992:233-239 (LeB4 promoter from a legume), these promoters
being suitable for dicots. Examples of promoters which are suitable for monocots are
the barley lpt-2 or lpt-1 promoter (WO 95/1 5389 and W O 95/23230), the barley
hordein promoter and other suitable promoters described in WO 99/16890. In principle,
it is possible to use all natural promoters together with their regulatory sequences, such
as those mentioned above, as expression control sequences. It is also possible to use
synthetic promoters, either in addition or alone, in particular when they mediate seed-
specific expression, as described, for example, in WO 99/16890.
In order to achieve a particularly high PUFA content, especially in transgenic plants,
the polynucleotides of the present invention should preferably be expressed in oil crops
in a seed-specific manner. To this end, seed-specific promoters can be used, or those
promoters which are active in the embryo and/or in the endosperm. In principle, seed-
specific promoters can be isolated both from dicotyledonous and from
monocotyledonous plants. Advantageous preferred promoters are listed hereinbelow:
USP (= unknown seed protein) and vicilin (Vicia faba) [Baumlein et al., MoI.
Gen Genet., 1991 , 225(3)], napin (oilseed rape) [US 5,608,152], acyl carrier protein
(oilseed rape) [US 5,315,001 and WO 92/18634], oleosin (Arabidopsis thaliana)
[WO 98/45461 and WO 93/2021 6], phaseolin (Phaseolus vulgaris) [US 5,504,200],
Bce4 [WO 91/1 3980], legumines B4 (LegB4 promoter) [Baumlein et al., Plant J., 2,2,
1992], Lpt2 and Ipt1 (barley) [WO 95/15389 and WO 95/23230], seed-specific
promoters from rice, maize and wheat [WO 99/16890], Amy32b, Amy 6-6 and aleurain
[US 5,677,474], Bce4 (oilseed rape) [US 5,530,149], glycinin (soybean) [EP 571 741],
phosphoenol pyruvate carboxylase (soybean) [JP 06/62870], ADR12-2 (soybean)
[WO 98/08962], isocitrate lyase (oilseed rape) [US 5,689,040] or α-amylase (barley)
[EP 781 849].
Plant gene expression can also be facilitated via a chemically inducible promoter (see
a review in Gatz 1997, Annu. Rev. Plant Physiol. Plant MoI. Biol., 48:89-108).
Chemically inducible promoters are particularly suitable when it is desired that gene
expression should take place in a time-specific manner. Examples of such promoters
are a salicylic acid-inducible promoter (WO 95/19443), a tetracycline-inducible
promoter (Gatz et al. (1992) Plant J. 2 , 397-404) and an ethanol-inducible promoter.
To ensure stable integration of the various biosynthesis genes into the transgenic plant
over a plurality of generations, each of the polynucleotides according to the invention
should be expressed under the control of a separate promoter, preferably a promoter
which differs from the other promoters, since repeating sequence motifs can lead to
instability of the T-DNA, or to recombination events. In this context, the expression
cassette is advantageously constructed in such a way that a promoter is followed by a
suitable cleavage site (advantageously in a polylinker) for insertion of the nucleic acid
to be expressed and, if appropriate, a terminator is then positioned behind the
polylinker. This sequence is repeated several times, preferably three, four or five times,
so that up to five genes can be combined in one construct and introduced into the
transgenic plant in order to be expressed. Advantageously, the sequence is repeated
up to three times. To express the nucleic acid sequences, the latter are inserted behind
the promoter via a suitable cleavage site, for example in the polylinker.
Advantageously, each nucleic acid sequence has its own promoter and, if appropriate,
its own terminator. Such advantageous constructs are disclosed, for example, in DE
101 02 337 or DE 101 02 338. However, it is also possible to insert a plurality of nucleic
acid sequences behind a promoter and, if appropriate, in front of a terminator. Here,
the insertion site, or the sequence, of the inserted nucleic acids in the expression
cassette is not of critical importance, that is to say a nucleic acid sequence can be
inserted at the first or last position in the cassette without its expression being
substantially influenced thereby. Advantageously, different promoters such as, for
example, the USP, LegB4 or DC3 promoters, and different terminators can be used in
the expression cassette. However, it is also possible to use only one type of promoter
in the cassette. This, however, may lead to undesired recombination events.
The recombinant expression vectors used can be designed for the expression in
prokaryotic or eukaryotic cells. This is advantageous since intermediate steps of the
vector construction are frequently carried out in microorganisms for the sake of
simplicity. For example, the ∆ 12-desaturase, ∆15-desaturase, ∆12- and ∆15-
desaturases, ω3-desaturase, ∆6-desaturase, ∆6-elongase, ∆9-elongase, ∆8-
desaturase, ∆5-desaturase, ∆5-elongase and/or ∆4-desaturase genes can be
expressed in bacterial cells, insect cells (using Baculovirus expression vectors), yeast
and other fungal cells (see Romanos, M.A., et al. (1992) "Foreign gene expression in
yeast: a review", Yeast 8:423-488; van den Hondel, C.A.M.J.J., et al. (1991)
"Heterologous gene expression in filamentous fungi", in: More Gene Manipulations in
Fungi, J.W. Bennet & L.L . Lasure, Eds., pp. 396-428: Academic Press: San Diego; and
van den Hondel, C.A.M.J.J., & Punt, PJ. (1991) "Gene transfer systems and vector
development for filamentous fungi, in: Applied Molecular Genetics of Fungi, Peberdy,
J.F., et al., Eds., pp. 1-28, Cambridge University Press: Cambridge), algae (Falciatore
et al., 1999, Marine Biotechnology.1 , 3:239-251), ciliates of the types: Holotrichia,
Peritrichia, Spirotrichia, Suctoria, Tetrahymena, Paramecium, Colpidium, Glaucoma,
Platyophrya, Potomacus, Desaturapseudocohnilembus, Euplotes, Engelmaniella and
Stylonychia, in particular of the genus Stylonychia lemnae, using vectors in a
transformation method as described in WO 98/01572 and, preferably, in cells of multi
cellular plants (see Schmidt, R. and Willmitzer, L. (1988) "High efficiency
Agrobacterium tumefaciens-mediated transformation of Arabidopsis thaliana leaf and
cotyledon explants" Plant Cell Rep.:583-586; Plant Molecular Biology and Biotechno
logy, C Press, Boca Raton, Florida, Chapter 6/7, pp. 71-1 19 (1993); F.F. White,
B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1,
Engineering and Utilization, Eds.: Kung and R. Wu, Academic Press (1993), 128-43;
Potrykus, Annu. Rev. Plant Physiol. Plant Molec. Biol. 42 (1991), 205-225 (and
references cited therein)). Suitable host cells are furthermore discussed in Goeddel,
Gene Expression Technology: Methods in Enzymology 185, Academic Press, San
Diego, CA ( 1990). As an alternative, the recombinant expression vector can be
transcribed and translated in vitro, for example using T7-promoter regulatory
sequences and T7-polymerase.
In most cases, the expression of proteins in prokaryotes involves the use of vectors
comprising constitutive or inducible promoters which govern the expression of fusion or
nonfusion proteins. Typical fusion expression vectors are, inter alia, pGEX (Pharmacia
Biotech Inc; Smith, D.B., and Johnson, K.S. (1988) Gene 67:31-40), pMAL (New
England Biolabs, Beverly, MA) and pRIT5 (Pharmacia, Piscataway, NJ), where
glutathione S-transferase (GST), maltose-E-binding protein and protein A , respectively,
are fused with the recombinant target protein. Examples of suitable inducible nonfusion
E. coli expression vectors are, inter alia, pTrc (Amann et al. (1988) Gene 69:301-315)
and pET 11d (Studier et al., Gene Expression Technology: Methods in Enzymology
185, Academic Press, San Diego, California (1990) 60-89). The target gene expression
from the vector pTrc is based on the transcription from a hybrid trp-lac fusion promoter
by the host RNA polymerase. The target gene expression from the vector pET 11d is
based on the transcription of a T7-gn10-lac fusion promoter, which is mediated by a
viral RNA polymerase (T7 gn1), which is coexpressed. This viral polymerase is
provided by the host strains BL21 (DE3) or HMS174 (DE3) from a resident λ-
prophagene which harbors a T7 gn1 gene under the transcriptional control of the lacUV
5 promoter. Other vectors which are suitable for prokaryotic organisms are known to
the skilled worker, these vectors are, for example in E. coli pLG338, pACYC1 84, the
pBR series such as pBR322, the pUC series such as pUC18 or pUC1 9 , the M 113mp
series, pKC30, pRep4, pHS1 , pHS2, pPLc236, pMBL24, pLG200, pUR290, plN-1111 13-
B 1 , λgt1 1 or pBdCI, in Streptomyces plJ101 , plJ364, plJ702 or plJ361 , in Bacillus
pUB1 10, pC194 or pBD214, in Corynebacterium pSA77 or pAJ667.
In a further embodiment, the expression vector is a yeast expression vector. Examples
of vectors for expression in the yeast S . cerevisiae comprise pYeDesaturased (Baldari
et al. ( 1987) Embo J . 6:229-234), pMFa (Kurjan and Herskowitz ( 1982) Cell 30:933-
943), pJRY88 (Schultz e t al. ( 1987) Gene 54:1 13-123) and pYES2 (Invitrogen
Corporation, San Diego, CA). Vectors and processes for the construction of vectors
which are suitable for use in other fungi, such as the filamentous fungi, comprise those
which are described in detail in: van den Hondel, C.A.M.J.J., & Punt, P.J. (1991) "Gene
transfer systems and vector development for filamentous fungi, in: Applied Molecular
Genetics of fungi, J.F. Peberdy et al., Ed., pp. 1-28, Cambridge University Press:
Cambridge, or in: More Gene Manipulations in Fungi [J.W. Bennet & L.L . Lasure, Eds.,
pp. 396-428: Academic Press: San Diego]. Further suitable yeast vectors are, for
example, pAG-1 , YEp6, YEp13 or pEMBLYe23.
As an alternative, the polynucleotides of the present invention can also be expressed in
insect cells using Baculovirus expression vectors. Baculovirus vectors which are
available for the expression of proteins in cultured insect cells (for example Sf9 cells)
comprise the pAc series (Smith et al. (1983) MoI. Cell Biol.. 3:2156-2165) and the pVL
series (Lucklow and Summers ( 1989) Virology 170:31-39).
Preferred plant expression vectors comprise those which are described in detail in:
Becker, D., Kemper, E., Schell, J., and Masterson, R. (1992) "New plant binary vectors
with selectable markers located proximal to the left border", Plant MoI. Biol. 20:1 195-
1197; and Bevan, M.W. ( 1984) "Binary Agrobacterium vectors for plant transformation",
Nucl. Acids Res. 12:871 1-8721 ; Vectors for Gene Transfer in Higher Plants; in:
Transgenic Plants, Vol. 1, Engineering and Utilization, Eds.: Kung and R. Wu,
Academic Press, 1993, p. 15-38. A plant expression cassette preferably comprises
expression control sequences which are capable of governing the expression of genes
in plant cells and which are linked operably so that each sequence can fulfill its
function, such as transcriptional termination, for example polyadenylation signals.
Preferred polyadenylation signals are those which are derived from Agrobacterium
tumefaciens T-DNA, such as gene 3 of the Ti plasmid pTiACH (Gielen et al., EMBO
J. 3 (1984) 835 et seq.), which is known as octopine synthase, or functional equivalents
thereof, but all other terminators which are functionally active in plants are also
suitable. Since plant gene expression is very often not limited to transcriptional levels, a
plant expression cassette preferably comprises other sequences which are linked
operably, such as translation enhancers, for example the overdrive sequence, which
comprises the tobacco mosaic virus 5'-untranslated leader sequence, which increases
the protein/RNA ratio (Gallie et al., 1987, Nucl. Acids Research 15:8693-871 1). As
described above, plant gene expression must be linked operably with a suitable
promoter which triggers gene expression with the correct timing or in a cell- or tissue-
specific manner. Utilizable promoters are constitutive promoters (Benfey et al., EMBO
J. 8 (1989) 2195-2202), such as those which are derived from plant viruses, such as
35S CAMV (Franck et al., Cell 2 1 (1980) 285-294), 19S CaMV (see also US 5352605
and WO 84/02913), or plant promoters, such as the promoter of the small Rubisco
subunit, which is described in US 4,962,028. Other preferred sequences for use in
operable linkage in plant gene expression cassettes are targeting sequences, which
are required for steering the gene product into its corresponding cell compartment (see
a review in Kermode, Crit. Rev. Plant Sci. 15, 4 (1996) 285-423 and references cited
therein), for example into the vacuole, into the nucleus, all types of plastids, such as
amyloplasts, chloroplasts, chromoplasts, the extracellular space, the mitochondria, the
endoplasmic reticulum, oil bodies, peroxisomes and other compartments of plant cells.
As described above, plant gene expression can also be facilitated via a chemically
inducible promoter (see review in Gatz 1997, Annu. Rev. Plant Physiol. Plant MoI. Biol.,
48:89-108). Chemically inducible promoters are particularly suitable when it is desired
that the gene expression takes place in a time-specific manner. Examples of such
promoters are a salicylic-acid-inducible promoter (WO 95/19443), a tetracyclin-
inducible promoter (Gatz et al. (1992) Plant J. 2 , 397-404) and an ethanol-inducible
promoter. Promoters which respond to biotic or abiotic stress conditions are also
suitable, for example the pathogen-induced PRP1 gene promoter (Ward et al., Plant.
MoI. Biol. 22 ( 1993) 361-366), the heat-inducible tomato hspδO promoter (US
5,187,267), the chill-inducible potato alpha-amylase promoter (WO 96/12814) or the
wound-inducible pinll promoter (EP-A-O 375 091).
Especially preferred are those promoters which bring about the gene expression in
tissues and organs in which the biosynthesis of fatty acids, lipids and oils takes place,
in seed cells, such as the cells of the endosperm and of the developing embryo.
Suitable promoters are the oilseed rape napin gene promoter (US 5,608,152), the Vicia
faba USP promoter (Baeumlein et al., MoI Gen Genet, 1991 , 225 (3):459-67), the
Arabidopsis oleosin promoter (WO 98/45461 ) , the Phaseolus vulgaris phaseolin
promoter (US 5,504,200), the Brassica Bce4 promoter (WO 91/1 3980) or the legumine
B4 promoter (LeB4; Baeumlein et al., 1992, Plant Journal, 2 (2):233-9), and promoters
which bring about the seed-specific expression in monocotyledonous plants such as
maize, barley, wheat, rye, rice and the like. Suitable noteworthy promoters are the
barley Ipt2 or Ipt1 gene promoter (WO 95/15389 and WO 95/23230) or the promoters
from the barley hordein gene, the rice glutelin gene, the rice oryzin gene, the rice
prolamine gene, the wheat gliadine gene, the wheat glutelin gene, the maize zeine
gene, the oat glutelin gene, the sorghum kasirin gene or the rye secalin gene, which
are described in WO 99/16890. Especially suitable promoters are likewise those which
bring about the plastid-specific expression, since plastids are the compartment in which
the precursors and some of the end products of lipid biosynthesis are synthesized.
Suitable promoters, such as the viral RNA polymerase promoter, are described in
WO 95/16783 and WO 97/06250, and the clpP promoter from Arabidopsis, described
in WO 99/46394.
The abovementioned vectors are only a small overview of possible vectors which are
suitable. Further plasmids are known to the skilled worker and are described for
example in: Cloning Vectors (eds. Pouwels, P.H., et al., Elsevier, Amsterdam-
New York-Oxford, 1985, ISBN 0 444 904018). Further suitable expression systems for
prokaryotic and eukaryotic cells, see chapters 16 and 17 of Sambrook, J., Fritsch, E.F.,
and Maniatis, T., Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor
Laboratory, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
As described above, the expression vector can, in addition to the polynucleotides
according to the invention, also comprise further genes which are to be introduced into
the organisms. It is possible and preferred to introduce into the host organisms, and
express in them, regulatory genes, such as genes for inductors, repressors or enzymes
which, as a result of their enzymatic activity, engage in the regulation of one or more
genes of a biosynthetic pathway. These genes can be of heterologous or homologous
origin. Heterologous genes or polynucleotides are derived from an organism of origin
which differs from the target organism into which the genes or polynucleotides are to
be introduced. In the case of homologous genes or polynucleotides, target organism
and organism of origin are identical. The vector therefore preferably comprises at least
one further polynucleotide which codes for a further enzyme which is involved in the
biosynthesis of lipids or fatty acids. The enzyme is preferably selected from the group
consisting of: acyl-CoA dehydrogenase(s), acyl-ACP [= acyl carrier protein]
desaturase(s), acyl-ACP thioesterase(s), fatty acid acyltransferase(s), acyl-
CoA:lysophospholipid acyltransferase(s), fatty acid synthase(s), fatty acid
hydroxylase(s), acetyl-coenzyme A carboxylase(s), acyl-coenzyme A oxidase(s), fatty
acid desaturase(s), fatty acid acetylenase(s), lipoxygenase(s), triacylglycerol lipase(s),
allene oxide synthase(s), hydroperoxide lyase(s), fatty acid elongase(s),
∆4-desaturase(s), ∆5-desaturase(s), ∆θ-desaturase(s), ∆δ-desaturase(s),
∆9-desaturase(s), ∆12-desaturase(s), ∆15-desaturase(s), ∆12- and ∆15-desaturase(s),
ω3-desaturase, ∆5-elongase(s), ∆θ-elongase(s) and ∆9-elongase(s).
Especially preferred gene combinations are listed in tables 5 and 6 in the examples
which follow.
The invention also relates to a host cell which comprises the polynucleotide according
to the invention or the vector according to the invention.
In principle, host cells for the purposes of the present invention may be all eukaryotic or
prokaryotic cells. They may be primary cells from animals, plants or multi-celled
microorganisms, for example from those which are mentioned in another place in the
description. The term furthermore also comprises cell lines which can be obtained from
these organisms.
However, host cells for the purposes of the invention may also be single-celled
microorganisms, for example bacteria or fungi. Especially preferred microorganisms
are fungi selected from the group of the families Chaetomiaceae, Choanephoraceae,
Cryptococcaceae, Cunninghamellaceae, Demetiaceae, Hydnangiaceae (genus
Laccaria), Moniliaceae, Mortierellaceae, Mucoraceae, Pythiaceae,
Sacharomycetaceae, Saprolegniaceae, Schizosacharomycetaceae, Sodariaceae or
Tuberculariaceae. Further preferred microorganisms are selected from the group:
Choanephoraceae, such as the genera Blakeslea, Choanephora, for example the
genera and species Blakeslea trispora, Choanephora cucurbitarum, Choanephora
infundibulifera var. cucurbitarum, Hydnangiaceae (for example genus Laccaria, in
particular species Laccaria bicoloή , Mortierellaceae, such as the genus Mortierella, for
example the genera and species Mortierella isabellina, Mortierella polycephala,
Mortierella ramanniana, Mortierella vinacea, Mortierella zonata, the family Mucorales,
such as the genera and species Rhizopus oryzae, Rhizopus stolonifer, Fusarium
graminearium, Pythiaceae, such as the genera Phytium, Phytophthora, for example the
genera and species Pythium debaryanum, Pythium intermedium, Pythium irregulare,
Pythium megalacanthum, Pythium paroecandrum, Pythium sylvaticum, Pythium
ultimum, Phytophthora cactorum, Phytophthora cinnamomi, Phytophthora citricola,
Phytophthora citrophthora, Phytophthora cryptogea, Phytophthora drechsleri,
Phytophthora erythroseptica, Phytophthora lateralis, Phytophthora megasperma,
Phytophthora nicotianae, Phytophthora nicotianae var. parasitica, Phytophthora
palmivora, Phytophthora parasitica, Phytophthora syringae, Saccharomycetaceae,
such as the genera Hansenula, Pichia, Saccharomyces, Saccharomycodes, Yarrowia,
for example the genera and species Hansenula anomala, Hansenula californica,
Hansenula canadensis, Hansenula capsulata, Hansenula ciferrii, Hansenula
glucozyma, Hansenula henricii, Hansenula holstii, Hansenula minuta, Hansenula
nonfermentans, Hansenula philodendri, Hansenula polymorpha, Hansenula saturnus,
Hansenula subpelliculosa, Hansenula wickerhamii, Hansenula wingei, Pichia
alcoholophila, Pichia angusta, Pichia anomala, Pichia bispora, Pichia burtonii, Pichia
canadensis, Pichia capsulata, Pichia carsonii, Pichia cellobiosa, Pichia ciferrii, Pichia
farinosa, Pichia fermentans, Pichia finlandica, Pichia glucozyma, Pichia guilliermondii,
Pichia haplophila, Pichia henricii, Pichia holstii, Pichia jadinii, Pichia lindnerii, Pichia
membranaefaciens, Pichia methanolica, Pichia minuta var. minuta, Pichia minuta var.
nonfermentans, Pichia norvegensis, Pichia ohmeri, Pichia pastoris, Pichia philodendri,
Pichia pini, Pichia polymorpha, Pichia quercuum, Pichia rhodanensis, Pichia
sargentensis, Pichia stipitis, Pichia strasburgensis, Pichia subpelliculosa, Pichia
toletana, Pichia trehalophila, Pichia vini, Pichia xylosa, Saccharomyces aceti,
Saccharomyces bailii, Saccharomyces bayanus, Saccharomyces bisporus,
Saccharomyces capensis, Saccharomyces carlsbergensis, Saccharomyces cerevisiae,
Saccharomyces cerevisiae var. ellipsoideus, Saccharomyces chevalieri,
Saccharomyces delbrueckii, Saccharomyces diastaticus, Saccharomyces
drosophilarum, Saccharomyces elegans, Saccharomyces ellipsoideus, Saccharomyces
fermentati, Saccharomyces florentinus, Saccharomyces fragilis, Saccharomyces
heterogenous, Saccharomyces hienipiensis, Saccharomyces inusitatus,
Saccharomyces italicus, Saccharomyces kluyveri, Saccharomyces krusei,
Saccharomyces lactis, Saccharomyces marxianus, Saccharomyces microellipsoides,
Saccharomyces montanus, Saccharomyces norbensis, Saccharomyces oleaceus,
Saccharomyces paradoxus, Saccharomyces pastorianus, Saccharomyces pretoriensis,
Saccharomyces rosei, Saccharomyces rouxii, Saccharomyces uvarum,
Saccharomycodes ludwigii, Yarrowia lipolytica, Schizosaccharomycetaceae such as
the genera Schizosaccharomyces e.g. the species Schizosaccharomyces japonicus
var. japonicus, Schizosaccharomyces japonicus var. versatilis, Schizosaccharomyces
malidevorans, Schizosaccharomyces octosporus, Schizosaccharomyces pombe var.
malidevorans, Schizosaccharomyces pombe var. pombe, Thraustochytriaceae such as
the genera Althorn ia , Apl a nochytrium, Japonochytrium, Schizochytrium,
Thraustochytrium e.g. the species Schizochytrium aggregatum, Schizochytrium
limacinum, Schizochytrium mangrovei, Schizochytrium minutum, Schizochytrium
octosporum, Thraustochytrium aggregatum, Thraustochytrium amoeboideum,
Thraustochytrium antacticum, Thraustochytrium arudimentale, Thraustochytrium
aureum, Thraustochytrium benthicola, Thraustochytrium globosum, Thraustochytrium
indicum, Thraustochytrium kergueiense, Thraustochytrium kinnei, Thraustochytrium
motivum, Thraustochytrium multirudimentale, Thraustochytrium pachydermum,
Thraustochytrium proliferum, Thraustochytrium roseum, Thraustochytrium rossii,
Thraustochytrium striatum or Thraustochytrium visurgense.
Equally preferred as microorganisms are bacteria selected from the group of the
families Bacillaceae, Enterobacteriacae or Rhizobiaceae. It is especially preferred to
mention the following bacteria selected from the group: Bacillaceae, such as the genus
Bacillus, for example the genera and species Bacillus acidocaldarius, Bacillus
acidoterrestris, Bacillus alcalophilus, Bacillus amyloliquefaciens, Bacillus amylolyticus,
Bacillus brevis, Bacillus cereus, Bacillus circulans, Bacillus coagulans, Bacillus
sphaericus subsp. fusiformis, Bacillus galactophilus, Bacillus globisporus, Bacillus
globisporus subsp. marinus, Bacillus halophilus, Bacillus lentimorbus, Bacillus lentus,
Bacillus licheniformis, Bacillus megaterium, Bacillus polymyxa, Bacillus
psychrosaccharolyticus, Bacillus pumilus, Bacillus sphaericus, Bacillus subtilis subsp.
spizizenii, Bacillus subtilis subsp. subtilis or Bacillus thuringiensis; Enterobacteriacae
such as the genera Citrobacter, Edwardsiella, Enterobacter, Erwinia, Escherichia,
Klebsiella, Salmonella or Serratia, for example the genera and species Citrobacter
amalonaticus, Citrobacter diversus, Citrobacter freundii, Citrobacter genomospecies,
Citrobacter gillenii, Citrobacter intermedium, Citrobacter koseri, Citrobacter murliniae,
Citrobacter sp., Edwardsiella hoshinae, Edwardsiella ictaluri, Edwardsiella tarda,
Erwinia alni, Erwinia amylovora, Erwinia ananatis, Erwinia aphidicola, Erwinia billingiae,
Erwinia cacticida, Erwinia cancerogena, Erwinia carnegieana, Erwinia carotovora
subsp. atroseptica, Erwinia carotovora subsp. betavasculorum, Erwinia carotovora
subsp. odorifera, Erwinia carotovora subsp. wasabiae, Erwinia chrysanthemi, Erwinia
cypripedii, Erwinia dissolvens, Erwinia herbicola, Erwinia mallotivora, Erwinia milletiae,
Erwinia nigrifluens, Erwinia nimipressuralis, Erwinia persicina, Erwinia psidii, Erwinia
pyrifoliae, Erwinia quercina, Erwinia rhapontici, Erwinia rubrifaciens, Erwinia salicis,
Erwinia stewartii, Erwinia tracheiphila, Erwinia uredovora, Escherichia adecarboxylata,
Escherichia anindolica, Escherichia aurescens, Escherichia blattae, Escherichia coli,
Escherichia coli var. communior, Escherichia coli-mutabile, Escherichia fergusonii,
Escherichia hermannii, Escherichia sp., Escherichia vulneris, Klebsiella aerogenes,
Klebsiella edwardsii subsp. atlantae, Klebsiella omithinolytica, Klebsiella oxytoca,
Klebsiella planticola, Klebsiella pneumoniae, Klebsiella pneumoniae subsp.
pneumoniae, Klebsiella sp., Klebsiella terrigena, Klebsiella trevisanii, Salmonella
abony, Salmonella arizonae, Salmonella bongori, Salmonella choleraesuis subsp.
arizonae, Salmonella choleraesuis subsp. bongori, Salmonella choleraesuis subsp.
cholereasuis, Salmonella choleraesuis subsp. diarizonae, Salmonella choleraesuis
subsp. houtenae, Salmonella choleraesuis subsp. indica, Salmonella choleraesuis
subsp. salamae, Salmonella daressalaam, Salmonella enterica subsp. houtenae,
Salmonella enterica subsp. salamae, Salmonella enteritidis, Salmonella gallinarum,
Salmonella heidelberg, Salmonella panama, Salmonella senftenberg, Salmonella
typhimurium, Serratia entomophila, Serratia ficaria, Serratia fonticola, Serratia grimesii,
Serratia liquefaciens, Serratia marcescens, Serratia marcescens subsp. marcescens,
Serratia marinorubra, Serratia odorifera, Serratia plymouthensis, Serratia plymuthica,
Serratia proteamaculans, Serratia proteamaculans subsp. quinovora, Serratia
quinivorans or Serratia rubidaea; Rhizobiaceae, such as the genera Agrobacterium,
Carbophilus, Chelatobacter, Ensifer, Rhizobium, Sinorhizobium, for example the
genera and species Agrobacterium atlanticum, Agrobacterium ferrugineum,
Agrobacterium gelatinovorum, Agrobacterium larrymoorei, Agrobacterium meteori,
Agrobacterium radiobacter, Agrobacterium rhizogenes, Agrobacterium rubi,
Agrobacterium stellulatum, Agrobacterium tumefaciens, Agrobacterium vitis,
Carbophilus carboxidus, Chelatobacter heintzii, Ensifer adhaerens, Ensifer arboris,
Ensifer fredii, Ensifer kostiensis, Ensifer kummerowiae, Ensifer medicae, Ensifer
meliloti, Ensifer saheli, Ensifer terangae, Ensifer xinjiangensis, Rhizobium ciceri,
Rhizobium etli, Rhizobium fredii, Rhizobium galegae, Rhizobium gallicum, Rhizobium
giardinii, Rhizobium hainanense, Rhizobium huakuii, Rhizobium huautlense, Rhizobium
indigoferae, Rhizobium japonicum, Rhizobium leguminosarum, Rhizobium loessense,
Rhizobium loti, Rhizobium lupini, Rhizobium mediterraneum, Rhizobium meliloti,
Rhizobium mongolense, Rhizobium phaseoli, Rhizobium radiobacter, Rhizobium
rhizogenes, Rhizobium rubi, Rhizobium sullae, Rhizobium tianshanense, Rhizobium
trifolii, Rhizobium tropici, Rhizobium undicola, Rhizobium vitis, Sinorhizobium
adhaerens, Sinorhizobium arboris, Sinorhizobium fredii, Sinorhizobium kostiense,
Sinorhizobium kummerowiae, Sinorhizobium medicae, Sinorhizobium meliloti,
Sinorhizobium morelense, Sinorhizobium saheli or Sinorhizobium xinjiangense.
Further utilizable host cells are detailed in: Goeddel, Gene Expression Technology:
Methods in Enzymology 185, Academic Press, San Diego, CA (1990). Expression
strains which can be used, for example those with a lower protease activity, are
described in: Gottesman, S., Gene Expression Technology: Methods in Enzymology
185, Academic Press, San Diego, California (1990) 119-128. These include plant cells
and certain tissues, organs and parts of plants in all their phenotypic forms such as
anthers, fibers, root hairs, stalks, embryos, calli, cotelydons, petioles, harvested
material, plant tissue, reproductive tissue and cell cultures which are derived from the
actual transgenic plant and/or can be used for bringing about the transgenic plant.
Polynucleotides or vectors can be introduced into the host cell as described above by
means of transformation or transfection methods which are known in the prior art.
Conditions and media for the cultivation of the host cells are also known to the skilled
worker.
The host cell according to the invention preferably additionally comprises at least one
further enzyme which is involved in the biosynthesis of lipids or fatty acids. Preferred
enzymes have already been mentioned in another place in the description. The
enzyme can be present in the host cell in endogenous form, i.e. the host cell already
naturally expresses a gene which codes for a corresponding enzyme. Alternatively, it is
also possible to introduce, into the host cell, a heterologous polynucleotide which
codes for the enzyme. Suitable methods and means for the expression of a
heterologous polynucleotide are known in the prior art and are described herein in
connection with the polynucleotides, vectors and host cells according to the invention.
The invention also relates to a method of generating a polypeptide with desaturase
activity, comprising the steps:
(a) expressing a polynucleotide according to the invention as defined above in
a host cell; and
(b) obtaining, from the host cell, the polypeptide which is encoded by the
polynucleotide in (a).
In this context, the polypeptide can be obtained or isolated by all current protein
purification methods. The methods comprise, for example, affinity chromatography,
molecular sieve chromatography, high-pressure liquid chromatography or else protein
precipitation, if appropriate with specific antibodies. Although this is preferred, the
process need not necessarily provide a pure polypeptide preparation.
The invention therefore also relates to a polypeptide which is encoded by the
polynucleotide according to the invention or which is obtainable by the abovementioned
method according to the invention.
The term "polypeptide" refers both to an essentially pure polypeptide, and also to a
polypeptide preparation which additionally comprises further components or impurities.
The term is also used for fusion proteins and protein aggregates which comprise the
polypeptide according to the invention and additionally further components. The term
also refers to chemically modified polypeptides. In this context, chemical modifications
comprise artificial modifications or naturally occurring modifications, for example
posttranslational modifications such as phosphorylation, myristylation, glycosylation
and the like. The terms polypeptide, peptide and protein are interchangeable and are
used accordingly in the description and in the prior art. The polypeptides according to
the invention have the abovementioned biological activities, that is to say desaturase
activities, and can influence the biosynthesis of polyunsaturated fatty acids (PUFAs),
preferably the long-chain PUFAs (LCPUFAs), as herein described.
The invention also comprises an antibody which specifically recognizes the polypeptide
according to the invention.
Antibodies against the polypeptide according to the invention can be prepared by
means of known methods, where purified polypeptide or fragments thereof with
suitable epitopes are used as the antigen. Suitable epitopes can be determined by
means of known algorithms for the antigenicity determination, based on the amino acid
sequences of the polypeptides according to the invention provided herein. The relevant
polypeptides or fragments can then be synthesized or obtained by recombinant
techniques. After suitable animals, preferably mammals, for example hares, rats or
mice, have been immunized, the antibodies can then be obtained from the serum,
using known methods. Alternatively, monoclonal antibodies or antibody fragments can
be provided with the known methods; see, for example, Harlow and Lane "Antibodies,
A Laboratory Manual", CSH Press, Cold Spring Harbor, 1988 or Kohler and Milstein,
Nature 256 (1975), 495, and GaIfre, Meth. Enzymol. 73 (1981), 3 .
The antibodies preferably take the form of monoclonal or polyclonal antibodies, single-
chain antibodies or chimeric antibodies, and fragments of these such as Fab, Fv or
scFv. Further antibodies within the meaning of the invention are bispecific antibodies,
synthetic antibodies or their chemically modified derivatives.
The antibodies according to the invention specifically recognize the polypeptides
according to the invention, that is to say they do not cross-react significantly with other
proteins. For example, an antibody according to the invention which specifically binds a
∆12-desaturase will not react with a ∆6-desaturase. This can be assayed by means of
methods known in the prior art. For example, the antibodies can be employed for the
purposes of detection reactions, immunoprecipitation, immunhistochemistry or protein
purification (for example affinity chromatography).
The invention furthermore relates to a transgenic, nonhuman organism which
comprises the polynucleotide, the vector or the host cell of the present invention. The
transgenic, nonhuman organism preferably takes the form of an animal, a plant or a
multicellular microorganism.
The term "transgenic" is understood as meaning that a heterologous polynucleotide,
that is to say a polynucleotide which does not occur naturally in the respective
organism, is introduced into the organism. This can be achieved either by random
insertion of the polynucleotide or by homologous recombination. Naturally, it is also
possible to introduce the vector according to the invention instead of the
polynucleotide. Methods of introducing polynucleotides or vectors for the purposes of
random insertion or homologous recombination are known in the prior art and also
described in greater detail hereinbelow. Host cells which comprise the polynucleotide
or the vector can also be introduced into an organism and thus generate a transgenic
organism. In such a case, such an organism takes the form of a chimeric organism,
where only those cells which are derived from the introduced cells are transgenic, i.e.
comprise the heterologous polynucleotide.
The transgenic nonhuman organisms are preferably oil-producing organisms, which
means organisms which are used for the production of oils, for example fungi such as
Rhizopus or Thraustochytrium, algae such as Euglena, Nephroselmis,
Pseudoscourfielda, Prasinococcus, Scherffelia, Tetraselmis, Mantoniella,
Ostreococcus, Crypthecodinium, Phaeodactylum, or diatoms such as Pythium or
Phytophthora or plants.
Transgenic plants which can be used are, in principle, all plants, that is to say both
dicotyledonous and monocotyledonous plants. They preferably take the form of oil crop
plants which comprise large amounts of lipid compounds, such as peanut, oilseed
rape, canola, sunflower, safflower (Carthamus tinctoria), poppy, mustard, hemp, castor-
oil plant, olive, sesame, Calendula, Punica, evening primrose, verbascum, thistle, wild
roses, hazelnut, almond, macadamia, avocado, bay, pumpkin/squash, linseed,
soybean, pistachios, borage, trees (oil palm, coconut or walnut) or arable crops such
as maize, wheat, rye, oats, triticale, rice, barley, cotton, cassava, pepper, Tagetes,
Solanaceae plants such as potato, tobacco, eggplant and tomato, Vicia species, pea,
alfalfa or bushy plants (coffee, cacao, tea), SaNx species, and perennial grasses and
fodder crops. Preferred plants according to the invention are oil crop plants such as
peanut, oilseed rape, canola, sunflower, safflower, poppy, mustard, hemp, castor-oil
plant, olive, Calendula, Punica, evening primrose, pumpkin/squash, linseed, soybean,
borage, trees (oil palm, coconut). Especially preferred are plants which are high in
C18:2- and/or C18:3-fatty acids, such as sunflower, tobacco, verbascum, sesame,
cotton, pumpkin/squash, poppy, evening primrose, walnut, linseed, hemp, thistle or
safflower. Very especially preferred plants are plants such as safflower, sunflower,
poppy, evening primrose, walnut, linseed or hemp. In principle, however, all plants
which are capable of synthesizing fatty acids are suitable, such as all dicotyledonous or
monocotyledonous plants, algae or mosses. Advantageous plants are selected from
the group of the plant families Adelotheciaceae, Anacardiaceae, Asteraceae, Apiaceae,
Betulaceae, Boraginaceae, Brassicaceae, Bromeliaceae, Caricaceae, Cannabaceae,
Convolvulaceae, Chenopodiaceae, Crypthecodiniaceae, Cucurbitaceae, Ditrichaceae,
Elaeagnaceae, Ericaceae, Euphorbiaceae, Fabaceae, Geraniaceae, Gramineae,
Juglandaceae, Lauraceae, Leguminosae, Linaceae, Prasinophyceae or vegetable
plants or ornamentals such as Tagetes.
Examples which may especially preferably be mentioned are the following plants
selected from the group consisting of: Adelotheciaceae such as the genera
Physcomitrella, for example the genus and species Physcomitrella patens,
Anacardiaceae such as the genera Pistacia, Mangifera, Anacardium, for example the
genus and species Pistacia vera [pistachio], Mangifer indica [mango] or Anacardium
occidentale [cashew], Asteraceae, such as the genera Calendula, Carthamus,
Centaurea, Cichorium, Cynara, Helianthus, Lactuca, Locusta, Tagetes, Valeriana, for
example the genus and species Calendula officinalis [common marigold], Carthamus
tinctorius [safflower], Centaurea cyanus [cornflower], Cichorium intybus [chicory],
Cynara scolymus [artichoke], Helianthus annus [sunflower], Lactuca sativa, Lactuca
crispa, Lactuca esculenta, Lactuca scariola L. ssp. sativa, Lactuca scariola L. var.
integrata, Lactuca scariola L. var. integrifolia, Lactuca sativa subsp. romana, Locusta
communis, Valeriana locusta [salad vegetables], Tagetes lucida, Tagetes erecta or
Tagetes tenuifolia [African or French marigold], Apiaceae, such as the genus Daucus,
for example the genus and species Daucus carota [carrot], Betulaceae, such as the
genus Corylus, for example the genera and species Corylus avellana or Corylus
colurna [hazelnut], Boraginaceae, such as the genus Borago, for example the genus
and species Borago officinalis [borage], Brassicaceae, such as the genera Brassica,
Camelina, Melanosinapis, Sinapis, Arabadopsis, for example the genera and species
Brassica napus, Brassica rapa ssp. [oilseed rape], Sinapis arvensis Brassica juncea,
Brassica juncea var. juncea, Brassica juncea var. crispifolia, Brassica juncea var.
foliosa, Brassica nigra, Brassica sinapioides, Camelina sativa, Melanosinapis
communis [mustard], Brassica oleracea [fodder beet] or Arabadopsis thaliana,
Bromeliaceae, such as the genera Ananas, Bromelia (pineapple), for example the
genera and species Ananas comosus, Ananas ananas or Bromelia comosa
[pineapple], Caricaceae, such as the genus Carica, such as the genus and species
Carica papaya [pawpaw], Cannabaceae, such as the genus Cannabis, such as the
genus and species Cannabis sative [hemp], Convolvulaceae, such as the genera
Ipomea, Convolvulus, for example the genera and species lpomoea batatus, lpomoea
pandurata, Convolvulus batatas, Convolvulus tiliaceus, lpomoea fastigiata, lpomoea
tiliacea, lpomoea triloba or Convolvulus panduratus [sweet potato, batate],
Chenopodiaceae, such as the genus Beta, such as the genera and species Beta
vulgaris, Beta vulgaris var. altissima, Beta vulgaris var. vulgaris, Beta maritima, Beta
vulgaris var. perennis, Beta vulgaris var. conditiva or Beta vulgaris var. esculenta
[sugarbeet], Crypthecodiniaceae, such as the genus Crypthecodinium, for example the
genus and species Cryptecodinium cohnii, Cucurbitaceae, such as the genus
Cucurbita, for example the genera and species Cucurbita maxima, Cucurbita mixta,
Cucurbita pepo or Cucurbita moschata [pumpkin/squash], Cymbellaceae, such as the
genera Amphora, Cymbella, Okedenia, Phaeodactylum, Reimeria, for example the
genus and species Phaeodactylum tricomutum, Ditrichaceae, such as the genera
Ditrichaceae, Astomiopsis, Ceratodon, Chrysoblastella, Ditrichum, Distichium,
Eccremidium, Lophidion, Philibertiella, Pleuridium, Saelania, Trichodon, Skottsbergia,
for example the genera and species Ceratodon antarcticus, Ceratodon columbiae,
Ceratodon heterophyllus, Ceratodon purpurascens, Ceratodon purpureus, Ceratodon
purpureus ssp. convolutus, Ceratodon purpureus ssp. stenocarpus, Ceratodon
purpureus var. rotundifolius, Ceratodon ratodon, Ceratodon stenocarpus,
Chrysoblastella chilensis, Ditrichum ambiguum, Ditrichum brevisetum, Ditrichum
crispatissimum, Ditrichum difficile, Ditrichum falcifolium, Ditrichum flexicaule, Ditrichum
giganteum, Ditrichum heteromallum, Ditήchum lineare, Ditήchum montanum, Ditrichum
pallidum, Ditrichum punctulatum, Ditrichum pusillum, Ditrichum pusillum var. tortile,
Ditrichum rhynchostegium, Ditrichum schimperi, Ditrichum tortile, Distichium
capillaceum, Distichium hagenii, Distichium inclinatum, Distichium macounii,
Eccremidium floridanum, Eccremidium whiteleggei, Lophidion strictus, Pleuridium
acuminatum, Pleuridium alternifolium, Pleuridium holdridgei, Pleuridium mexicanum,
Pleuridium ravenelii, Pleuridium subulatum, Saelania glaucescens, Trichodon borealis,
Trichodon cylindricus or Trichodon cylindricus var. oblongus, Elaeagnaceae, such as
the genus Elaeagnus, for example the genus and species Olea europaea [olive],
Ericaceae, such as the genus Kalmia, for example the genera and species Kalmia
latifolia, Kalmia angustifolia, Kalmia microphylla, Kalmia polifolia, Kalmia occidentalis,
Cistus chamaerhodendros or Kalmia lucida [mountain laurel], Euphorbiaceae, such as
the genera Manihot, Janipha, Jatropha, Ricinus, for example the genera and species
Manihot utilissima, Janipha manihot, Jatropha manihot, Manihot aipil, Manihot dulcis,
Manihot manihot, Manihot melanobasis, Manihot esculenta [cassava] or Ricinus
communis [castor-oil plant], Fabaceae, such as the genera Pisum, Albizia, Cathormion,
Feuillea, Inga, Pithecolobium, Acacia, Mimosa, Medicago, Glycine, Dolichos,
Phaseolus, soybean, for example the genera and species Pisum sativum, Pisum
arvense, Pisum humile [pea], Albizia berteriana, Albizia julibrissin, Albizia lebbeck,
Acacia berteriana, Acacia littoralis, Albizia berteriana, Albizzia berteriana, Cathormion
berteriana, Feuillea berteriana, Inga fragrans, Pithecellobium berterianum,
Pithecellobium fragrans, Pithecolobium berterianum, Pseudalbizzia berteriana, Acacia
julibrissin, Acacia nemu, Albizia nemu, Feuilleea julibrissin, Mimosa julibrissin, Mimosa
speciosa, Sericandra julibrissin, Acacia lebbeck, Acacia macrophylla, Albizia lebbeck,
Feuilleea lebbeck, Mimosa lebbeck, Mimosa speciosa [silk tree], Medicago sativa,
Medicago falcata, Medicago varia [alfalfa] Glycine max Dolichos soja, Glycine gracilis,
Glycine hispida, Phaseolus max, Soja hispida or Soja max [soybean], Funariaceae,
such as the genera Aphanorrhegma, Entosthodon, Funaria, Physcomitrella,
Physcomitrium, for example the genera and species Aphanorrhegma serratum,
Entosthodon attenuatus, Entosthodon bolanderi, Entosthodon bonplandii, Entosthodon
californicus, Entosthodon drummondii, Entosthodon jamesonii, Entosthodon leibergii,
Entosthodon neoscoticus, Entosthodon rubrisetus, Entosthodon spathulifolius,
Entosthodon tucsoni, Funaria americana, Funaria bolanderi, Funaria calcarea, Funaria
californica, Funaria calvescens, Funaria convoluta, Funaria flavicans, Funaria
groutiana, Funaria hygrometrica, Funaria hygrometrica var. arctica, Funaria
hygrometrica var. calvescens, Funaria hygrometrica var. convoluta, Funaria
hygrometrica var. muralis, Funaria hygrometrica var. utahensis, Funaria microstoma,
Funaria microstoma var. obtusifolia, Funaria muhlenbergii, Funaria orcuttii, Funaria
plano-convexa, Funaria polaris, Funaria ravenelii, Funaria rubriseta, Funaria serrata,
Funaria sonorae, Funaria sublimbatus, Funaria tucsoni, Physcomitrella californica,
Physcomitrella patens, Physcomitrella reader!, Physcomitrium australe, Physcomitrium
californicum, Physcomitrium collenchymatum, Physcomitrium coloradense,
Physcomitrium cupuliferum, Physcomitrium drummondii, Physcomitrium eurystomum,
Physcomitrium flexifolium, Physcomitrium hookeri, Physcomitrium hookeri var.
serratum, Physcomitrium immersum, Physcomitrium kellermanii, Physcomitrium
megalocarpum, Physcomitrium pyriforme, Physcomitrium pyriforme var. serratum,
Physcomitrium rufipes, Physcomitrium sandbergii, Physcomitrium subsphaericum,
Physcomitrium washingtoniense, Geraniaceae, such as the genera Pelargonium,
Cocos, Oleum, for example the genera and species Cocos nucifera, Pelargonium
grossularioides or Oleum cocois [coconut], Gramineae, such as the genus Saccharum,
for example the genus and species Saccharum officinarum, Juglandaceae, such as the
genera Juglans, Wallia, for example the genera and species Juglans regia, Juglans
ailanthifolia, Juglans sieboldiana, Juglans cinerea, Wallia cinerea, Juglans bixbyi,
Juglans californica, Juglans hindsii, Juglans intermedia, Juglans jamaicensis, Juglans
major, Juglans microcarpa, Juglans nigra or Wallia nigra [walnut], Lauraceae, such as
the genera Persea, Laurus, for example the genera and species Laurus nobilis [bay],
Persea americana, Persea gratissima or Persea persea [avocado], Leguminosae, such
as the genus Arachis, for example the genus and species Arachis hypogaea [peanut],
Linaceae, such as the genera Linum, Adenolinum, for example the genera and species
Linum usitatissimum, Linum humile, Linum austriacum, Linum bienne, Linum
angustifolium, Linum catharticum, Linum flavum, Linum grandiflorum, Adenolinum
grandiflorum, Linum lewisii, Linum narbonense, Linum perenne, Linum perenne var.
lewisii, Linum pratense or Linum trigynum [linseed], Lythrarieae, such as the genus
Punica, for example the genus and species Punica granatum [pomegranate],
Malvaceae, such as the genus Gossypium, for example the genera and species
Gossypium hirsutum, Gossypium arboreum, Gossypium barbadense, Gossypium
herbaceum or Gossypium thurberi [cotton], Marchantiaceae, such as the genus
Marchantia, for example the genera and species Marchantia berteroana, Marchantia
foliacea, Marchantia macropora, Musaceae, such as the genus Musa, for example the
genera and species Musa nana, Musa acuminata, Musa paradisiaca, Musa spp.
[banana], Onagraceae, such as the genera Camissonia, Oenothera, for example the
genera and species Oenothera biennis or Camissonia brevipes [evening primrose],
Palmae, such as the genus Elacis, for example the genus and species Elaeis
guineensis [oil palm], Papaveraceae, such as the genus Papaver, for example the
genera and species Papaver orientate, Papaver rhoeas, Papaver dubium [poppy],
Pedaliaceae, such as the genus Sesamum, for example the genus and species
Sesamum indicum [sesame], Piperaceae, such as the genera Piper, Artanthe,
Peperomia, Steffensia, for example the genera and species Piper aduncum, Piper
amalago, Piper angustifolium, Piper auritum, Piper betel, Piper cubeba, Piper longum,
Piper nigrum, Piper retrofractum, Artanthe adunca, Artanthe elongata, Peperomia
elongata, Piper elongatum, Steffensia elongata [cayenne pepper], Poaceae, such as
the genera Hordeum, Secale, Avena, Sorghum, Andropogon, Holcus, Panicum, Oryza,
Zea (maize), Triticum, for example the genera and species Hordeum vulgare, Hordeum
jubatum, Hordeum murinum, Hordeum secalinum, Hordeum distichon, Hordeum
aegiceras, Hordeum hexastichon, Hordeum hexastichum, Hordeum irregulare,
Hordeum sativum, Hordeum secalinum [barley], Secale cereale [rye], Avena sativa,
Avena fatua, Avena byzantina, Avena fatua var. sativa, Avena hybrida [oats], Sorghum
bicolor, Sorghum halepense, Sorghum saccharatum, Sorghum vulgare, Andropogon
drummondii, Holcus bicolor, Holcus sorghum, Sorghum aethiopicum, Sorghum
arundinaceum, Sorghum caffrorum, Sorghum cernuum, Sorghum dochna, Sorghum
drummondii, Sorghum durra, Sorghum guineense, Sorghum lanceolatum, Sorghum
nervosum, Sorghum saccharatum, Sorghum subglabrescens, Sorghum verticilliflorum,
Sorghum vulgare, Holcus halepensis, Sorghum miliaceum, Panicum militaceum [millet],
Oryza sativa, Oryza latifolia [rice], Zea mays [maize] Triticum aestivum, Triticum
durum, Triticum turgidum, Triticum hybernum, Triticum macha, Triticum sativum or
Triticum vulgare [wheat], Porphyridiaceae, such as the genera Chroothece, Flintiella,
Petrovanella, Porphyridium, Rhodella, Rhodosorus, Vanhoeffenia, for example the
genus and species Porphyridium cruentum, Proteaceae, such as the genus
Macadamia, for example the genus and species Macadamia intergrifolia [macadamia],
Prasinophyceae, such as the genera Nephroselmis, Prasinococcus, Scherffelia,
Tetraselmis, Mantoniella, Ostreococcus, for example the genera and species
Nephroselmis olivacea, Prasinococcus capsulatus, Scherffelia dubia, Tetraselmis chui,
Tetraselmis suecica, Mantoniella squamata, Ostreococcus tauri, Rubiaceae, such as
the genus Coffea, for example the genera and species Coffea spp., Coffea arabica,
Coffea canephora or Coffea liberica [coffee], Scrophulariaceae, such as the genus
Verbascum, for example the genera and species Verbascum blattaria, Verbascum
chaixii, Verbascum densiflorum, Verbascum lagurus, Verbascum Iongifolium,
Verbascum lychnitis, Verbascum nigrum, Verbascum olympicum, Verbascum
phlomoides, Verbascum phoenicum, Verbascum pulverulentum or Verbascum thapsus
[verbascum], Solanaceae, such as the genera Capsicum, Nicotiana, Solanum,
Lycopersicon, for example the genera and species Capsicum annuum, Capsicum
annuum var. glabriusculum, Capsicum frutescens [pepper], Capsicum annuum
[paprika], Nicotiana tabacum, Nicotiana alata, Nicotiana attenuata, Nicotiana glauca,
Nicotiana langsdorffii, Nicotiana obtusifolia, Nicotiana quadrivalvis, Nicotiana repanda,
Nicotiana rustica, Nicotiana sylvestris [tobacco], Solanum tuberosum [potato], Solanum
melongena [eggplant], Lycopersicon esculentum, Lycopersicon lycopersicum,
Lycopersicon pyriforme, Solanum integrifolium or Solanum lycopersicum [tomato],
Sterculiaceae, such as the genus Theobroma, for example the genus and species
Theobroma cacao [cacao] or Theaceae, such as the genus Camellia, for example the
genus and species Camellia sinensis [tea].
Multicellular microorganisms which can be employed as transgenic nonhuman
organisms are preferably protists or diatoms selected from the group of the families
Dinophyceae, Turaniellidae or Oxytrichidae, such as the genera and species:
Crypthecodinium cohnii, Phaeodactylum tricomutum, Stylonychia mytilus, Stylonychia
pustulata, Stylonychia putrina, Stylonychia notophora, Stylonychia sp., Colpidium
campylum or Colpidium sp.
The invention further relates to a process for the production of a substance which has
the structure shown in the general formula I hereinbelow
wherein the variables and substituents are as follows:
R1 = hydroxyl, coenzyme A (thioester), lysophosphatidylcholine,
lysophosphatidylethanolamine, lysophosphatidylglycerol, lyso-
diphosphatidylglycerol, lysophosphatidylserine, lysophosphatidylinositol,
sphingo base or a radical of the formula I l
R2 = hydrogen, phosphatidylcholine, phosphatidylethanolamine, phosphatidyl-
serine, phosphatidylinositol or a saturated or unsaturated C 2 to C24-
alkylcarbonyl,
R3 = hydrogen, a saturated or unsaturated C 2 to C24-alkylcarbonyl, or R2 and R3
independently of one another are a radical of the formula Ia:
in which
n = 2 , 3 , 4 , 5 , 6 , 7 or 9 , m = 2 , 3 , 4 , 5 or 6 and p = 0 or 3 ;
and wherein the process comprises the cultivation of (i) a host cell according to the
invention or (ii) of a transgenic, nonhuman organism according to the invention under
conditions which permit the biosynthesis of the substance. Preferably, the
abovementioned substance is provided in an amount of at least 1% by weight based on
the total lipid content in the host cell or the transgenic organism.
Preferred alkyl radicals R2 which may be mentioned are substituted or unsubstituted,
saturated o r unsaturated C2-C24-alkylcarbonyl chains such as ethylcarbonyl, n-
propylcarbonyl, n-butylcarbonyl, n-pentylcarbonyl, n-hexylcarbonyl, n-heptylcarbonyl, n-
octylcarbonyl, n-nonylcarbonyl, n-decylcarbonyl, n-undecylcarbonyl, n-
dodecylcarbonyl, n-tridecylcarbonyl, n-tetradecylcarbonyl, n-pentadecylcarbonyl, n-
hexadecylcarbonyl, n-heptadecylcarbonyl, n-octadecylcarbonyl, n-nonadecylcarbonyl,
n-eicosylcarbonyl, n-docosanylcarbonyl or n-tetracosanylcarbonyl, which comprise one
or more double bonds. Saturated or unsaturated Cio-C22-alkylcarbonyl radicals such as
n-decylcarbonyl, n-undecylcarbonyl, n-dodecylcarbonyl, n-tridecylcarbonyl,
n-tetradecylcarbonyl, n-pentadecylcarbonyl, n-hexadecylcarbonyl, n-
heptadecylcarbonyl, n-octadecylcarbonyl, n-nonadecylcarbonyl, n-eicosylcarbonyl, n-
docosanylcarbonyl or n-tetracosanylcarbonyl, which comprise one or more double
bonds are preferred. Especially preferred are saturated and/or unsaturated C10-C22-
alkylcarbonyl radicals such as Cio-alkylcarbonyl, Cn-alkylcarbonyl, Ci2-alkylcarbonyl,
Ci3-alkylcarbonyl, Cu-alkylcarbonyl, Ci -alkylcarbonyl, Cis-alkylcarbonyl, C20-
alkylcarbonyl or C22-alkylcarbonyl radicals which comprise one or more double bonds.
Very especially preferred are saturated or unsaturated Ci6-C22-alkylcarbonyl radicals
such as Ci6-alkylcarbonyl, Cis-alkylcarbonyl, C2o-alkylcarbonyl or C22-alkylcarbonyl
radicals which comprise one or more double bonds. These preferred radicals can
comprise two, three, four, five or six double bonds. The especially preferred radicals
with 20 or 22 carbon atoms in the fatty acid chain comprise up to six double bonds,
preferably three, four, five or six double bonds, especially preferably five or six double
bonds. All the abovementioned radicals are derived from the corresponding fatty acids.
Preferred alkyl radicals R3 which may be mentioned are substituted or unsubstituted,
saturated or unsaturated C2-C24-alkylcarbonyl chains such as ethylcarbonyl, n-
propylcarbonyl, n-butylcarbonyl, n-pentylcarbonyl, n-hexylcarbonyl, n-heptylcarbonyl, n-
octylcarbonyl, n-nonylcarbonyl, n-decylcarbonyl, n-undecylcarbonyl, n-
dodecylcarbonyl, n-tridecylcarbonyl, n-tetradecylcarbonyl, n-pentadecylcarbonyl, n-
hexadecylcarbonyl, n-heptadecylcarbonyl, n-octadecylcarbonyl, n-nonadecylcarbonyl,
n-eicosylcarbonyl, n-docosanylcarbonyl or n-tetracosanylcarbonyl, which comprise one
or more double bonds. Saturated or unsaturated Cio-C22-alkylcarbonyl radicals such as
n-decylcarbonyl, n-undecylcarbonyl, n-dodecylcarbonyl, n-tridecylcarbonyl,
n-tetradecylcarbonyl, n-pentadecylcarbonyl, n-hexadecylcarbonyl,
n-heptadecylcarbonyl, n-octadecylcarbonyl, n-nonadecylcarbonyl, n-eicosylcarbonyl,
n-docosanylcarbonyl or n-tetracosanylcarbonyl, which comprise one or more double
bonds are preferred. Especially preferred are saturated and/or unsaturated C10-C22-
alkylcarbonyl radicals such as Cio-alkylcarbonyl, Cn-alkylcarbonyl, Ci2-alkylcarbonyl,
Ci3-alkylcarbonyl, Cu-alkylcarbonyl, Ci -alkylcarbonyl, Cis-alkylcarbonyl, C20-
alkylcarbonyl or C22-alkylcarbonyl radicals which comprise one or more double bonds.
Very especially preferred are saturated or unsaturated Ci6-C22-alkylcarbonyl radicals
such a s Ci6-alkylcarbonyl, Cis-alkylcarbonyl, C2o-alkylcarbonyl or C22-alkylcarbonyl
radicals which comprise one or more double bonds. These preferred radicals can
comprise two, three, four, five or six double bonds. The especially preferred radicals
with 20 or 22 carbon atoms in the fatty acid chain comprise up to six double bonds,
preferably three, four, five or six double bonds, especially preferably five or six double
bonds. All the abovementioned radicals are derived from the corresponding fatty acids.
The abovementioned radicals of R1, R2 and R3 can be substituted by hydroxyl and/or
epoxy groups and/or can comprise triple bonds.
The polyunsaturated fatty acids produced in the process according to the invention
advantageously comprise at least two, advantageously three, four, five or six, double
bonds. The fatty acids especially advantageously comprise four, five or six double
bonds. Fatty acids produced in the process advantageously have 18, 20 or 22 C atoms
in the fatty acid chain; the fatty acids preferably comprise 20 or 22 carbon atoms in the
fatty acid chain. Saturated fatty acids are advantageously reacted to a minor degree, or
not at all, with the nucleic acids used in the process. To a minor degree is to be
understood as meaning that the saturated fatty acids are reacted with less than 5% of
the activity, advantageously less than 3%, especially advantageously with less than
2%, very especially preferably with less than 1, 0.5, 0.25 or 0.125% in comparison with
polyunsaturated fatty acids. These fatty acids which have been produced can be
produced in the process as a single product or be present in a fatty acid mixture.
The radicals R2 or R3 in the general formulae I l may be indentical or non-identical, R2
and R3 preferably being a saturated or unsaturated Ci8-C22-alkylcarbonyl, especially
preferably an unsaturated Ciβ- , C20- or C22-alkylcarbonyl with at least two double
bonds.
The polyunsaturated fatty acids produced in the process are advantageously bound in
membrane lipids and/or triacylglycerides, but may also occur in the organisms as free
fatty acids or else bound in the form of other fatty acid esters. In this context, they may
be present as "pure products" or else advantageously in the form of mixtures of various
fatty acids or mixtures of different glycerides. The various fatty acids which are bound
in the triacylglycerides can be derived from short-chain fatty acids with 4 to 6 C atoms,
medium-chain fatty acids with 8 to 12 C atoms or long-chain fatty acids with 14 to 24 C
atoms; preferred are long-chain fatty acids, more preferably long-chain fatty acids
LCPUFAs of Ci8-,.C 2o- and/or C22- fatty acids.
The process according to the invention advantageously yields fatty acid esters with
polyunsaturated C18-, C20- and/or C22-fatty acid molecules with at least two double
bonds in the fatty acid ester, advantageously with at least three, four, five or six double
bonds in the fatty acid ester, especially advantageously with at least five or six double
bonds in the fatty acid ester and advantageously leads to the synthesis of linoleic acid
(=LA, C 18:2 ∆9 12) , γ-linolenic acid (= GLA, C 18:3 ∆6 9 12) , stearidonic acid (= SDA,
C18:4 ∆6'9'12 '15) , dihomo- γ-linolenic acid (= DGLA, 20:3 ∆8 1 4) , ω3-eicosatetraenoic acid
(= ETA, C20:4 A H I arachidonic acid (ARA, C20:4 A H - eicosapentaenoic acid
( E P A , C 2 0 : 5∆5 8 1 1 14 7) , ω6-docosapentaenoic acid (C22:5 ∆4 10 13 6) ,
ω6-docosatetraenoic acid (C22:4 ∆ 7 '10 '13 '16) , ω 3-docosapentaenoic acid (= DPA,
C22:5 ∆7 10 13 16 9) , docosahexaenoic acid (= DHA, C22:6 ∆4 10 13 16 9) o r mixtures of
these, preferably ARA, EPA and/or DHA. ω3-Fatty acids such as EPA and/or DHA are
very especially preferably produced.
The fatty acid esters with polyunsaturated Ciβ- , C20- and/or C22-fatty acid molecules
can be isolated in the form of an oil or lipid, for example in the form of compounds such
as sphingolipids, phosphoglycerides, lipids, glycolipids such as glycosphingolipids,
phospholipids such a s phosphatidylethanolamine, phosphatidylcholine,
phosphatidylserine, phosphatidylglycerol, phosphatidylinositol or
diphosphatidylglycerol, monoacylglycerides, diacylglycerides, triacylglycerides or other
fatty acid esters such as the acyl-coenzyme A esters which comprise the
polyunsaturated fatty acids with at least two, three, four, five or six, preferably five or
six double bonds, from the organisms which have been used for the preparation of the
fatty acid esters; advantageously, they are isolated in the form of their diacylglycerides,
triacylglycerides and/or in the form of phosphatidylcholine, especially preferably in the
form of the triacylglycerides. In addition to these esters, the polyunsaturated fatty acids
are also present in the organisms, advantageously the plants, as free fatty acids or
bound in other compounds. As a rule, the various abovementioned compounds (fatty
acid esters and free fatty acids) are present in the organisms with an approximate
distribution of 80 to 90% by weight of triglycerides, 2 to 5% by weight of diglycerides, 5
to 10% by weight of monoglycerides, 1 to 5% by weight of free fatty acids, 2 to 8% by
weight of phospholipids, the total of the various compounds amounting to 100% by
weight.
The process according to the invention yields the LCPUFAs produced in a content of at
least 3% by weight, advantageously at least 5% by weight, preferably at least 8% by
weight, especially preferably at least 10% by weight, most preferably at least 15% by
weight, based on the total fatty acids in the transgenic organisms, advantageously in a
transgenic plant. In this context, it is advantageous to convert Ciβ- and/or C2o-fatty
acids which are present in the host organisms to at least 10%, advantageously to at
least 20%, especially advantageously to at least 30%, most advantageously to at least
40% to give the corresponding products such as DPA or DHA, to mention just two
examples. The fatty acids are advantageously produced in bound form. These
unsaturated fatty acids can, with the aid of the nucleic acids used in the process
according to the invention, be positioned at the sn1 , sn2 and/or sn3 position of the
advantageously produced triglycerides. Since a plurality of reaction steps are
performed by the starting compounds linoleic acid (C18:2) and linolenic acid (C18:3) in
the process according to the invention, the end products of the process such as, for
example, arachidonic acid (ARA), eicosapentaenoic acid (EPA), ω6-docosapentaenoic
acid or DHA are not obtained as absolutely pure products; minor traces of the
precursors are always present in the end product. If, for example, both linoleic acid and
linolenic acid are present in the starting organism and the starting plant, the end
products such as ARA, EPA or DHA are present as mixtures. The precursors should
advantageously not amount to more than 20% by weight, preferably not to more than
15% by weight, especially preferably not to more than 10% by weight, most preferably
not to more than 5% by weight, based on the amount of the end product in question.
Advantageously, only ARA, EPA or only DHA, bound or as free acids, are produced as
end products in a transgenic plant in the process according to the invention. If the
compounds ARA, EPA and DHA are produced simultaneously, they are
advantageously produced in a ratio of at least 3:2:1 (EPA:ARA:DHA).
Fatty acid esters or fatty acid mixtures produced by the process according to the
invention advantageously comprise 6 to 15% of palmitic acid, 1 to 6% of stearic acid, 7-
85% of oleic acid, 0.5 to 8% of vaccenic acid, 0.1 to 1% of arachic acid, 7 to 25% of
saturated fatty acids, 8 to 85% of monounsaturated fatty acids and 60 to 85% of
polyunsaturated fatty acids, in each case based on 100% and on the total fatty acid
content of the organisms. Advantageous polyunsaturated fatty acid which is present in
the fatty acid esters or fatty acid mixtures is preferably eicosapentaenoic acid.
Moreover, the fatty acid esters or fatty acid mixtures which have been produced by the
process of the invention advantageously comprise fatty acids selected from the group
of the fatty acid s erucic acid ( 13-docosaenoic acid), sterculic acid (9,10-
methyleneoctadec-9-enoic acid), malvalic acid (8,9-methyleneheptadec-8-enoic acid),
chaulmoogric acid (cyclopentenedodecanoic acid) , furan fatty acid (9, 12-
epoxyoctadeca-9,1 1-dienoic acid), vernolic acid (9,1 0-epoxyoctadec-12-enoic acid),
tannic acid (6-octadecynoic acid), 6-nonadecynoic acid, santalbic acid (t1 1-octadecen-
9-ynoic acid), 6,9-octadecenynoic acid, pyrulic acid (t1 0-heptadecen-8-ynoic acid),
crepenynic acid (9-octadecen-12-ynoic acid), 13,14-dihydrooropheic acid, octadecen-
13-ene-9,1 1-diynoic acid, petroselinic acid (cis-6-octadecenoic acid), 9c,12t-
octadecadienoic acid, calendulic acid (8t10t12c-octadecatrienoic acid), catalpic acid
(9t1 1t13c-octadecatrienoic acid), eleostearic acid (9c1 1t13t-octadecatrienoic acid),
jacaric acid (8c10t12c-octadecatrienoic acid), punicic acid (9c1 1t13c-octadecatrienoic
acid), parinaric acid (9c1 1t13t15c-octadecatetraenoic acid), pinolenic acid (all-cis-
5,9,12-octadecatrienoic acid), laballenic acid (5,6-octadecadienallenic acid), ricinoleic
acid (12-hydroxyoleic acid) and/or coriolic acid (13-hydroxy-9c,1 1t-octadecadienoic
acid). The abovementioned fatty acids are, as a rule, advantageously only found in
traces in the fatty acid esters or fatty acid mixtures produced by the process according
to the invention, that is to say that, based on the total fatty acids, they occur to less
than 30%, preferably to less than 25%, 24%, 23%, 22% or 2 1%, especially preferably
to less than 20%, 15%, 10%, 9%, 8%, 7%, 6% or 5%, very especially preferably to less
than 4%, 3%, 2% or 1%. The fatty acid esters or fatty acid mixtures produced by the
process according to the invention advantageously comprise less than 0.1 %, based on
the total fatty acids, o r no butyric acid, no cholesterol, no clupanodonic acid
(= docosapentaenoic acid, C22:5 ∆4'8'12'15'2 1) and no nisinic acid (tetracosahexaenoic
acid, C23:6∆3 8 12 15 1821 ) .
Owing to the nucleic acid sequences of the invention, or the nucleic acid sequences
used in the process according to the invention, a n increase in the yield of
polyunsaturated fatty acids of at least 50%, advantageously of at least 80%, especially
advantageously of at least 100%, very especially advantageously of at least 150%, in
comparison with the nontransgenic starting organism, for example a yeast, an alga, a
fungus or a plant such as Arabidopsis or linseed can be obtained in a comparison by
GC analysis.
Chemically pure polyunsaturated fatty acids or fatty acid compositions can also be
prepared by the processes described above. To this end, the fatty acids or the fatty
acid compositions are isolated from the organism, such as the microorganisms or the
plants or the culture medium in or on which the organisms have been grown, or from
the organism and the culture medium, in a known manner, for example via extraction,
distillation, crystallization, chromatography or combinations of these methods. These
chemically pure fatty acids or fatty acid compositions are advantageous for applications
in the food industry sector, the cosmetic industry sector and especially the
pharmacological industry sector.
In principle, all genes of the fatty acid or lipid metabolism can be used in the process
for the production of polyunsaturated fatty acids, advantageously in combination with
the inventive polynucleotide(s) (for the purposes of the present application, the plural is
understood as encompassing the singular and vice versa). Genes of the fatty acid or
lipid metabolism which are used are advantageously selected from the group
consisting of acyl-CoA dehydrogenase(s), acyl-ACP [= acyl carrier protein]
desaturase(s), acyl-ACP thioesterase(s), fatty acid acyltransferase(s), acyl-
CoA:lysophospholipid acyltransferases, fatty acid synthase(s) , fatty acid
hydroxylase(s), acetyl-coenzyme A carboxylase(s), acyl-coenzyme A oxidase(s), fatty
acid desaturase(s), fatty acid acetylenases, lipoxygenases, triacylglycerol lipases,
allene oxide synthases, hydroperoxide lyases or fatty acid elongase(s). Genes selected
from the group of the ∆4-desaturases, ∆5-desaturases, ∆6-desaturases, ∆8-
desaturases, ∆9-desaturases, ∆ 12-desaturases, ∆ 15-desaturases, ∆ 12- and ∆ 15-
desaturases, ω3-desaturases, ∆6-elongases, ∆9-elongases or ∆5-elongases in
combination with the polynucleotides according to the invention are preferably used, it
being possible to use individual genes or a plurality of genes in combination. For
especially preferred gene combinations, reference is made here to tables 5 and 6 ,
which are shown in the examples.
Advantageously, the desaturases used in the process according to the invention
convert their respective substrates in the form of the CoA-fatty acid esters. If preceded
by an elongation step, this advantageously results in an increased product yield. The
respective desaturation products are thereby synthesized in greater quantities, since
the elongation step is usually carried out with the CoA-fatty acid esters, while the
desaturation step is predominantly carried out with the phospholipids or the
triglycerides. Therefore, a substitution reaction between the CoA-fatty acid esters and
the phospholipids or triglycerides, which would require a further, possibly limiting,
enzyme reaction, is not necessary.
Owing to the enzymatic activity of the polypeptides used in the process according to
the invention, a wide range of polyunsaturated fatty acids can be produced in the
process according to the invention. Depending on the choice of the organisms, such as
the preferred plants, used for the process according to the invention, mixtures of the
various polyunsaturated fatty acids or individual polyunsaturated fatty acids, such as
EPA or ARA, can be produced in free or bound form. Depending on the prevailing fatty
acid composition in the starting plant (C1 8:2- or C18:3-fatty acids), fatty acids which
are derived from C 18:2-fatty acids, such as GLA, DGLA or ARA, or fatty acids which
are derived from C18:3-fatty acids, such as SDA, ETA or EPA, are thus obtained. If
only linoleic acid (= LA, C18:2∆9 2) is present as unsaturated fatty acid in the plant used
for the process, the process can only afford GLA, DGLA and ARA as products, all of
which can be present as free fatty acids or in bound form. If only α-linolenic acid
(= ALA, C18:3∆9'12'15) is present as unsaturated fatty acid in the plant used for the
process, the process can only afford SDA, ETA, EPA and/or DHA as products, all of
which can be present as free fatty acids or in bound form, as described above. Owing
to the modification of the activity of the enzymes ∆5-desaturase, ∆6-desaturase,
∆4-desaturase, ∆12-desaturase, ∆ 15-desaturase, ω3-desaturase, ∆5-elongase and/or
∆6-elongase which play a role in the synthesis, it is possible to produce, in a targeted
fashion, only individual products in the abovementioned organisms, advantageously in
the abovementioned plants. Owing to the activity of ∆6-desaturase and ∆6-elongase,
for example, GLA and DGLA, or SDA and ETA, are formed, depending on the starting
plant and unsaturated fatty acid. DGLA or ETA or mixtures of these are preferably
formed. If ∆5-desaturase, ∆5-elongase and ∆4-desaturase are additionally introduced
into the organisms, advantageously into the plant, ARA, EPA and/or DHA are
additionally formed. Advantageously, only ARA, EPA or DHA or mixtures of these are
synthesized, depending on the fatty acids present in the organism, or in the plant,
which acts as starting substance for the synthesis. Since biosynthetic cascades are
involved, the end products in question are not present as pure substances in the
organisms. Small amounts of the precursor compounds are always additionally present
in the end product. These small amounts amount to less than 20% by weight,
advantageously less than 15% by weight, especially advantageously less than 10% by
weight, most advantageously less than 5 , 4 , 3 , 2 or 1% by weight, based on the end
product DGLA, ETA or their mixtures, or ARA, EPA, DHA or their mixtures,
advantageously EPA or DHA or their mixtures.
In addition to the production, directly in the organism, of the starting fatty acids for the
polypeptides used in the process of the invention, the fatty acids can also be fed
externally. The production in the organism is preferred for reasons of economy.
Preferred substrates are linoleic acid (C1 8:2∆9 2) , γ-linolenic acid (C18:3∆6'9 2) ,
eicosadienoic acid (C20:2∆1 1M ) , dihomo-γ-linolenic acid (C20:3∆8 1M ) , arachidonic acid
(C20:4∆5'8'1 1M ) , docosatetraenoic acid (C22:4 ∆710 '13 '16) and docosapentaenoic acid
(C22:5∆4'7'10'13'15) .
To increase the yield in the described process for the production of oils and/or
triglycerides with an advantageously elevated content of polyunsaturated fatty acids, it
is advantageous to increase the amount of starting product for the synthesis of fatty
acids; this can be achieved for example by introducing, into the organism, a nucleic
acid which codes for a polypeptide with a ∆12-desaturase and/or (15-desaturase
activity according to the invention. This is particularly advantageous in oil-producing
organisms such as those from the family of the Brassicaceae, such as the genus
Brassica, for example oilseed rape; the family of the Elaeagnaceae, such as the genus
Elaeagnus, for example the genus and species Olea europaea, or the family
Fabaceae, such as the genus Glycine, for example the genus and species Glycine
max, which are high in oleic acid. Since these organisms are only low in linoleic acid
(Mikoklajczak et al., Journal of the American Oil Chemical Society, 38, 1961 , 678 -
68 1) , the use of the abovementioned ∆12-desaturases and/or (15-desaturases
according to the invention for producing the starting material linoleic acid is
advantageous.
The process according to the invention advantageously employs the abovementioned
nucleic acid sequences or their derivatives or homologs which code for polypeptides
which retain the enzymatic activity of the proteins encoded by nucleic acid sequences.
These sequences, individually or in combination with the polynucleotides according to
the invention, are cloned into expression constructs and used for the introduction into,
and expression in, organisms. Owing to their construction, these expression constructs
make possible an advantageous optimal synthesis of the polyunsaturated fatty acids
produced in the process according to the invention.
In a preferred embodiment, the process furthermore comprises the step of obtaining a
cell or an intact organism which comprises the nucleic acid sequences used in the
process, where the cell and/or the organism is transformed with a polynucleotide
according to the invention, a gene construct or a vector as described below, alone or in
combination with further nucleic acid sequences which code for proteins of the fatty
acid or lipid metabolism. In a further preferred embodiment, this process furthermore
comprises the step of obtaining the oils, lipids or free fatty acids from the organism or
from the culture. The culture can, for example, take the form of a fermentation culture,
for example in the case of the cultivation of microorganisms, such as, for example,
Mortierella, Thalassiosira, Mantoniella, Ostreococcus, Saccharomyces or
Thraustochytrium, or a greenhouse- or field-grown culture of a plant. The cell or the
organism thus produced is advantageously a cell of an oil-producing organism, such as
an oil crop, such as, for example, peanut, oilseed rape, canola, linseed, hemp,
soybean, safflower, sunflowers or borage.
In the case of plant cells, plant tissue or plant organs, "growing" is understood as
meaning, for example, the cultivation on or in a nutrient medium, or of the intact plant
on or in a substrate, for example in a hydroponic culture, potting compost or on arable
land.
Suitable organisms or host cells for the process according to the invention are those
which are capable of synthesizing fatty acids, specifically unsaturated fatty acids,
and/or which are suitable for the expression of recombinant genes. Examples which
may be mentioned are plants such as Arabidopsis, Asteraceae such as Calendula or
crop plants such as soybean, peanut, castor-oil plant, sunflower, maize, cotton, flax,
oilseed rape, coconut, oil palm, safflower (Carthamus tinctorius) or cacao bean,
microorganisms, such as fungi, for example the genus Mortierella, Thraustochytrium,
Saprolegnia, Phytophthora or Pythium, bacteria, such as the genus Escherichia or
Shewanella, yeasts, such as the genus Saccharomyces, cyanobacteria, ciliates, algae
such as Mantoniella or Ostreococcus, or protozoans such as dinoflagellates, such as
Thalassiosira or Crypthecodinium. Preferred organisms are those which are naturally
capable of synthesizing substantial amounts of oil, such as fungi, such as Mortierella
alpina, Pythium insidiosum, Phytophthora infestans, or plants such as soybean, oilseed
rape, coconut, oil palm, safflower, flax, hemp, castor-oil plant, Calendula, peanut,
cacao bean or sunflower, or yeasts such as Saccharomyces cerevisiae, with soybean,
flax, oilseed rape, safflower, sunflower, Calendula, Mortierella or Saccharomyces
cerevisiae being especially preferred. In principle, suitable as host organisms are, in
addition to the abovementioned transgenic organisms, also transgenic animals,
advantageously nonhuman animals, for example Caenorhabditis elegans. Further
suitable host cells and organisms have already been described extensively above.
Transgenic plants which comprise the polyunsaturated fatty acids synthesized in the
process according to the invention can advantageously be marketed directly without
there being any need for the oils, lipids or fatty acids synthesized to be isolated. Plants
for the process according to the invention are listed as meaning intact plants and all
plant parts, plant organs or plant parts such as leaf, stem, seeds, root, tubers, anthers,
fibers, root hairs, stalks, embryos, calli, cotelydons, petioles, harvested material, plant
tissue, reproductive tissue and cell cultures which are derived from the transgenic plant
and/or can be used for bringing about the transgenic plant. In this context, the seed
comprises all parts of the seed such as the seed coats, epidermal cells, seed cells,
endosperm or embryonic tissue. However, the compounds produced in the process
according to the invention can also be isolated from the organisms, advantageously
plants, in the form of their oils, fats, lipids and/or free fatty acids. Polyunsaturated fatty
acids produced by this process can be obtained by harvesting the organisms, either
from the crop in which they grow, or from the field. This can be done via pressing or
extraction of the plant parts, preferably of the plant seeds. In this context, the oils, fats,
lipids and/or free fatty acids can be obtained by pressing by what is known as cold-
beating or cold-pressing without applying heat. To allow for greater ease of disruption
of the plant parts, specifically the seeds, they are previously comminuted, steamed or
roasted. The seeds which have been pretreated in this manner can subsequently be
pressed or extracted with solvent such as warm hexane. The solvent is subsequently
removed. In the case of microorganisms, the latter are, after harvesting, for example
extracted directly without further processing steps or else, after disruption, extracted via
various methods with which the skilled worker is familiar. In this manner, more than
96% of the compounds produced in the process can be isolated. Thereafter, the
resulting products are processed further, i.e. refined. In this process, for example the
plant mucilages and suspended matter are first removed. What is known as desliming
can be effected enzymatically or, for example, chemico-physically by addition of acid
such as phosphoric acid. Thereafter, the free fatty acids are removed by treatment with
a base, for example sodium hydroxide solution. The resulting product is washed
thoroughly with water to remove the alkali remaining in the product and then dried. To
remove the pigments remaining in the product, the products are subjected to bleaching,
for example using fuller's earth or active charcoal. At the end, the product is
deodorized, for example using steam.
The PUFAs or LCPUFAs produced by this process are preferably Ciβ- , C20- or C22-fatty
acid molecules, advantageously C20- o r C22-fatty acid molecules, with at least two
double bonds in the fatty acid molecule, preferably three, four, five or six double bonds.
These C18-, C20- or C22-fatty acid molecules can be isolated from the organism in the
form of an oil, a lipid or a free fatty acid. Suitable organisms are, for example, those
mentioned above. Preferred organisms are transgenic plants.
One embodiment of the invention is therefore oils, lipids or fatty acids or fractions
thereof which have been produced by the abovedescribed process, especially
preferably oil, lipid or a fatty acid composition comprising PUFAs and being derived
from transgenic plants.
These oils, lipids or fatty acid compositions preferably comprise the abovementioned
fatty acids, particularly preferably in the abovementioned concentration. In one
embodiment of the invention, the oils, lipids or fatty acid compositions obtained by the
methods according to the invention are distinguished by the fact that the preparations
which comprise said oils, lipids or fatty acid compositions contain traces of the nucleic
acids according to the invention. These traces can be detected by suitable highly-
sensitive detection methods, for example PCR-based technologies.
A further embodiment according to the invention is the use of the oil, lipid, the fatty
acids and/or the fatty acid composition in feedstuffs, foodstuffs, cosmetics o r
pharmaceuticals. The oils, lipids, fatty acids or fatty acid mixtures according to the
invention can be used in the manner with which the skilled worker is familiar for mixing
with other oils, lipids, fatty acids or fatty acid mixtures of animal origin, such as, for
example, fish oils. These oils, lipids, fatty acids or fatty acid mixtures, which are
composed of vegetable and animal constituents, may also be used for the preparation
of feedstuffs, foodstuffs, cosmetics or pharmaceuticals.
The term "oil", "lipid" or "fat" is understood as meaning a fatty acid mixture comprising
unsaturated, saturated, preferably esterified, fatty acid(s). The oil, lipid or fat is
preferably high in polyunsaturated free or, advantageously, esterified fatty acid(s), in
particular those mentioned above. The amount of unsaturated esterified fatty acids
preferably amounts to approximately 30%, a content of 50% is more preferred, a
content of 60%, 70%, 80% or more is even more preferred. For the analysis, the fatty
acid content can, for example, be determined by gas chromatography after converting
the fatty acids into the methyl esters by transesterification. The oil, lipid or fat can
comprise various other saturated or unsaturated fatty acids, for example calendulic
acid, palmitic acid, palmitoleic acid, stearic acid, oleic acid and the like. The content of
the various fatty acids in the oil or fat can vary, in particular depending on the starting
organism.
The polyunsaturated fatty acids with advantageously at least two double bonds which
are produced in the process are, as described above, for example sphingolipids,
phosphoglycerides, lipids, glycolipids, phospholipids, monoacylglycerol, diacylglycerol,
triacylglycerol or other fatty acid esters.
Starting from the polyunsaturated fatty acids with advantageously at least five or six
double bonds, which acids have been prepared in the process according to the
invention, the polyunsaturated fatty acids which are present can be liberated for
example via treatment with alkali, for example aqueous KOH or NaOH, or acid
hydrolysis, advantageously in the presence of an alcohol such as methanol or ethanol,
or via enzymatic cleavage, and isolated via, for example, phase separation and
subsequent acidification via, for example, H2SO4. The fatty acids can also be liberated
directly without the abovedescribed processing step.
After their introduction into an organism, advantageously a plant cell or plant, the
nucleic acids used in the process can either be present on a separate plasmid or,
advantageously, integrated into the genome of the host cell. In the case of integration
into the genome, integration can be random or else be effected by recombination such
that the native gene is replaced by the copy introduced, whereby the production of the
desired compound by the cell is modulated, or by the use of a gene in "trans", so that
the gene is linked operably with a functional expression unit which comprises at least
one sequence which ensures the expression of a gene and at least one sequence
which ensures the polyadenylation of a functionally transcribed gene. The nucleic acids
are advantageously introduced into the organisms via multiexpression cassettes or
constructs for multiparallel expression, advantageously into the plants for the
multiparallel seed-specific expression of genes.
Mosses and algae are the only known plant systems which produce substantial
amounts of polyunsaturated fatty acids such as arachidonic acid (ARA) and/or
eicosapentaenoic acid (EPA) and/or docosahexaenoic acid (DHA). Mosses comprise
PUFAs in membrane lipids, while algae, organisms which are related to algae and a
few fungi also accumulate substantial amounts of PUFAs in the triacylglycerol fraction.
This is why nucleic acid molecules which are isolated from such strains that also
accumulate PUFAs in the triacylglycerol fraction are particularly advantageous for the
process according to the invention and thus for the modification of the lipid and PUFA
production system in a host, in particular plants such as oil crops, for example oilseed
rape, canola, linseed, hemp, soybeans, sunflowers and borage. They can therefore be
used advantageously in the process according to the invention.
Substrates which are suitable for the polypeptides according to the invention of the
fatty acid or lipid metabolism selected from the group acyl-CoA dehydrogenase(s),
acyl-ACP [= acyl carrier protein] desaturase(s), acyl-ACP thioesterase(s), fatty acid
acyltransferase(s), acyl-CoA:lysophospholipid acyltransferase(s), fatty acid
synthase(s), fatty acid hydroxylase(s), acetyl-coenzyme A carboxylase(s), acyl-
coenzyme A oxidase(s), fatty acid desaturase(s), fatty acid acetylenase(s),
lipoxygenase(s), triacylglycerol lipase(s), allene oxide synthase(s), hydroperoxide
lyase(s) or fatty acid elongase(s) are preferably C16-, Ciβ- or C2o-fatty acids. The fatty
acids converted as substrates in the process are preferably converted in the form of
their acyl-CoA esters and/or their phospholipid esters.
To produce the long-chain PUFAs according to the invention, the polyunsaturated
Ci8-fatty acids must first be desaturated by the enzymatic activity of a desaturase and
subsequently be elongated by at least two carbon atoms via an elongase. After one
elongation cycle, this enzyme activity gives C2o-fatty acids and after two elongation
cycles, C22-fatty acids. The activity of the desaturases and elongases used in the
processes according to the invention preferably leads to Ciβ- , C20- and/or C22-fatty
acids, advantageously with at least two double bonds in the fatty acid molecule,
preferably with three, four, five or six double bonds, especially preferably to C20- and/or
C22-fatty acids with at least two double bonds in the fatty acid molecule, preferably with
three, four, five or six double bonds, very especially preferably with five or six double
bonds in the molecule. After a first desaturation and the elongation have taken place,
further desaturation and elongation steps such as, for example, such a desaturation in
the ∆5 and ∆4 positions may take place. Products of the process according to the
invention which are especially preferred are dihomo- γ-linolenic acid, arachidonic acid,
eicosapentaenoic acid, docosapentaenoic acid and/or docosahexaenoic acid. The
C2o-fatty acids with at least two double bonds in the fatty acid can be desaturated by
the enzymatic activity according to the invention in the form of the free fatty acid or in
the form of the esters, such a s phospholipids, glycolipids, sphingolipids,
phosphoglycerides, monoacylglycerol, diacylglycerol or triacylglycerol.
The preferred biosynthesis site of fatty acids, oils, lipids or fats in the plants which are
advantageously used is, for example, in general the seed or cell strata of the seed, so
that seed-specific expression of the nucleic acids used in the process is sensible.
However, it is obvious that the biosynthesis of fatty acids, oils or lipids need not be
limited to the seed tissue, but can also take place in a tissue-specific manner in all the
other parts of the plant - for example in epidermal cells or in the tubers.
If microorganism such as yeasts, such as Saccharomyces or Schizosaccharomyces,
fungi such as Mortierella, Aspergillus, Phytophthora, Entomophthora, Mucor or
Thraustochytrium , algae such a s Isochrysis, Mantoniella, Ostreococcus,
Phaeodactylum or Crypthecodinium are used as organisms in the process according to
the invention, these organisms are advantageously grown in fermentation cultures.
Owing to the use of the nucleic acids according to the invention which code for a
desaturase, the polyunsaturated fatty acids produced in the process can be increased
by at least 5%, preferably by at least 10%, especially preferably by at least 20%, very
especially preferably by at least 50% in comparison with the wild type of the organisms
which do not comprise the nucleic acids recombinantly.
In principle, the polyunsaturated fatty acids produced by the process according to the
invention in the organisms used in the process can be increased in two different ways.
Advantageously, the pool of free polyunsaturated fatty acids and/or the content of the
esterified polyunsaturated fatty acids produced via the process can be enlarged.
Advantageously, the pool of esterified polyunsaturated fatty acids in the transgenic
organisms is enlarged by the process according to the invention.
If microorganisms are used as organisms in the process according to the invention,
they are grown or cultured in a manner with which the skilled worker is familiar,
depending on the host organism. As a rule, microorganisms are grown in a liquid
medium comprising a carbon source, usually in the form of sugars, a nitrogen source,
usually in the form of organic nitrogen sources such as yeast extract or salts such as
ammonium sulfate, trace elements such as salts of iron, manganese and magnesium
and, if appropriate, vitamins, at temperatures of between 0 C and 100 C, preferably
between 10 C and 60°C, while introducing oxygen gas. The pH of the nutrient liquid
can either be kept constant, that is to say regulated during the culturing period, or not.
The cultures can be grown batchwise, semi-batchwise or continuously. Nutrients can
be provided at the beginning of the fermentation or fed in semicontinuously or
continuously. The polyunsaturated fatty acids produced can be isolated from the
organisms as described above by processes known to the skilled worker, for example
by extraction, distillation, crystallization, if appropriate precipitation with salt, and/or
chromatography. To this end, the organisms can advantageously be disrupted
beforehand.
If the host organisms are microorganisms, the process according to the invention is
advantageously carried out at a temperature of between 0 C and 95°C, preferably
between 10 C and 85°C, especially preferably between 15°C and 75°C, very especially
preferably between 15°C and 45°C.
In this process, the pH value is advantageously kept between pH 4 and 12, preferably
between pH 6 and 9 , especially preferably between pH 7 and 8 .
The process according to the invention can be operated batchwise, semibatchwise or
continuously. An overview of known cultivation methods can be found in the textbook
by Chmiel (Bioproze βtechnik 1. Einfuhrung in die Bioverfahrenstechnik [Bioprocess
technology 1. Introduction to bioprocess technology] (Gustav Fischer Verlag, Stuttgart,
1991 )) or in the textbook by Storhas (Bioreaktoren und periphere Einrichtungen
[Bioreactors and peripheral equipment] (Vieweg Verlag, Brunswick/Wiesbaden, 1994)).
The culture medium to be used must suitably meet the requirements of the strains in
question. Descriptions of culture media for various microorganisms can be found in the
textbook "Manual of Methods for General Bacteriology" of the American Society for
Bacteriology (Washington D.C , USA, 1981).
As described above, these media which can be employed in accordance with the
invention usually comprise one or more carbon sources, nitrogen sources, inorganic
salts, vitamins and/or trace elements.
Preferred carbon sources are sugars, such as mono-, di- or polysaccharides. Examples
of very good carbon sources are glucose, fructose, mannose, galactose, ribose,
sorbose, ribulose, lactose, maltose, sucrose, raffinose, starch or cellulose. Sugars can
also be added to the media via complex compounds such as molasses or other by
products from sugar raffination. The addition of mixtures of a variety of carbon sources
may also be advantageous. Other possible carbon sources are oils and fats such as,
for example, soya oil, sunflower oil, peanut oil and/or coconut fat, fatty acids such as,
for example, palmitic acid, stearic acid and/or linoleic acid, alcohols and/or polyalcohols
such as, for example, glycerol, methanol and/or ethanol, and/or organic acids such as,
for example, acetic acid and/or lactic acid.
Nitrogen sources are usually organic or inorganic nitrogen compounds or materials
comprising these compounds. Examples of nitrogen sources comprise ammonia in
liquid or gaseous form or ammonium salts such as ammonium sulfate, ammonium
chloride, ammonium phosphate, ammonium carbonate or ammonium nitrate, nitrates,
urea, amino acids or complex nitrogen sources such as cornsteep liquor, soya meal,
soya protein, yeast extract, meat extract and others. The nitrogen sources can be used
individually or as a mixture.
Inorganic salt compounds which may be present in the media comprise the chloride,
phosphorus and sulfate salts of calcium, magnesium, sodium, cobalt, molybdenum,
potassium, manganese, zinc, copper and iron.
Inorganic sulfur-containing compounds such as, for example, sulfates, sulfites,
dithionites, tetrathionates, thiosulfates, sulfides, or else organic sulfur compounds such
as mercaptans and thiols may be used as sources of sulfur for the production of sulfur-
containing fine chemicals, in particular of methionine.
Phosphoric acid, potassium dihydrogen phosphate or dipotassium hydrogen phosphate
or the corresponding sodium-containing salts may be used as sources of phosphorus.
Chelating agents may be added to the medium in order to keep the metal ions in
solution. Particularly suitable chelating agents comprise dihydroxyphenols such as
catechol or protocatechuate and organic acids such as citric acid.
The fermentation media used according to the invention for cultivating microorganisms
usually also comprise other growth factors such as vitamins or growth promoters,
which include, for example, biotin, riboflavin, thiamine, folic acid, nicotinic acid,
panthothenate and pyridoxine. Growth factors and salts are frequently derived from
complex media components such as yeast extract, molasses, cornsteep liquor and the
like. It is moreover possible to add suitable precursors to the culture medium. The
exact composition of the media compounds depends heavily on the particular
experiment and is decided upon individually for each specific case. Information on the
optimization of media can be found in the textbook "Applied Microbiol. Physiology, A
Practical Approach" (Editors P.M. Rhodes, P.F. Stanbury, IRL Press (1997) pp. 53-73,
ISBN 0 19 963577 3). Growth media can also be obtained from commercial suppliers,
for example Standard 1 (Merck) or BHI (brain heart infusion, DIFCO) and the like.
All media components are sterilized, either by heat (20 min at 1.5 bar and 121 C) or by
filter sterilization. The components may be sterilized either together or, if required,
separately. All media components may be present at the start of the cultivation or
added continuously or batchwise, as desired.
The culture temperature is normally between 15°C and 45°C, preferably at from 25°C
to 40 C, and may be kept constant or altered during the experiment. The pH of the
medium should be in the range from 5 to 8.5, preferably around 7.0. The pH for
cultivation can be controlled during cultivation by adding basic compounds such as
sodium hydroxide, potassium hydroxide, ammonia and aqueous ammonia or acidic
compounds such as phosphoric acid or sulfuric acid. Foaming can be controlled by
employing antifoams such as, for example, fatty acid polyglycol esters. To maintain the
stability of plasmids it is possible to add to the medium suitable substances having a
selective effect, for example antibiotics. Aerobic conditions are maintained by
introducing oxygen or oxygen-containing gas mixtures such as, for example, ambient
air, into the culture. The temperature of the culture is normally 20 C to 45°C and
preferably 25°C to 40 C. The culture is continued until formation of the desired product
is at a maximum. This aim is normally achieved within 10 hours to 160 hours.
The fermentation broths obtained in this way, in particular those containing
polyunsaturated fatty acids, usually contain a dry mass of from 7.5 to 25% by weight.
The fermentation broth can then be processed further. The biomass may, according to
requirement, be removed completely or partially from the fermentation broth by
separation methods such as, for example, centrifugation, filtration, decanting or a
combination of these methods or be left completely in said broth. It is advantageous to
process the biomass after its separation.
However, the fermentation broth can also be thickened or concentrated without
separating the cells, using known methods such as, for example, with the aid of a
rotary evaporator, thin-film evaporator, falling-film evaporator, by reverse osmosis or by
nanofiltration. Finally, this concentrated fermentation broth can be processed to obtain
the fatty acids present therein.
The polynucleotides or polypeptides of the present invention which are involved in the
metabolism of lipids and fatty acids, PUFA cofactors and enzymes or in the transport of
lipophilic compounds across membranes are used in the process according to the
invention for the modulation of the production of PUFAs in transgenic organisms,
advantageously in plants, such as maize, wheat, rye, oats, triticale, rice, barley,
soybean, peanut, cotton, Linum species such as linseed or flax, Brassica species such
as oilseed rape, canola and turnip rape, pepper, sunflower, borage, evening primrose
and Tagetes, Solanaceae plants such as potato, tobacco, eggplant and tomato, Vicia
species, pea, cassava, alfalfa, bushy plants (coffee, cacao, tea), SaNx species, trees
(oil palm, coconut) and perennial grasses and fodder crops, either directly (for example
when the overexpression or optimization of a fatty acid biosynthesis protein has a
direct effect on the yield, production and/or production efficiency of the fatty acid from
modified organisms) and/or can have an indirect effect which nevertheless leads to an
enhanced yield, production and/or production efficiency of the PUFAs or a reduction of
undesired compounds (for example when the modulation of the metabolism of lipids
and fatty acids, cofactors and enzymes leads to modifications of the yield, production
and/or production efficiency or the composition of the desired compounds within the
cells, which, in turn, can affect the production of one or more fatty acids).
The combination of various precursor molecules and biosynthesis enzymes leads to
the production of various fatty acid molecules, which has a decisive effect on lipid
composition, since polyunsaturated fatty acids (= PUFAs) are not only easily
incorporated into triacylglycerol but also into membrane lipids.
Brassicaceae, Boraginaceae, Primulaceae, or Linaceae are particularly suitable for the
production of PUFAs, for example stearidonic acid, eicosapentaenoic acid and
docosahexaenoic acid. Linseed (Linum usitatissimum) is especially advantageously
suitable for the production of PUFAs with the nucleic acid sequences according to the
invention, advantageously, as described, in combination with further desaturases and
elongases.
Lipid synthesis can be divided into two sections: the synthesis of fatty acids and their
binding to sn-glycerol-3-phosphate, and the addition or modification of a polar head
group. Usual lipids which are used in membranes comprise phospholipids, glycolipids,
sphingolipids and phosphoglycerides. Fatty acid synthesis starts with the conversion of
acetyl-CoA into malonyl-CoA by acetyl-CoA carboxylase or into acetyl-ACP by acetyl
transacylase. After a condensation reaction, these two product molecules together form
acetoacetyl-ACP, which is converted via a series of condensation, reduction and
dehydratation reactions so that a saturated fatty acid molecule with the desired chain
length is obtained. The production of the unsaturated fatty acids from these molecules
is catalyzed by specific desaturases, either aerobically by means of molecular oxygen
or anaerobically (regarding the fatty acid synthesis in microorganisms, see F.C .
Neidhardt et al. ( 1996) E. coli and Salmonella. ASM Press: Washington, D.C ,
pp. 612-636 and references cited therein; Lengeler et al. (Ed.) ( 1999) Biology of
Procaryotes. Thieme: Stuttgart, New York, and the references therein, and Magnuson,
K., et al. ( 1993) Microbiological Reviews 57:522-542 and the references therein). To
undergo the further elongation steps, the resulting phospholipid-bound fatty acids must
be returned to the fatty acid CoA ester pool from the phospholipids. For further
desaturation as described above, the fatty acid can be transferred back into the
phospholipid pool. If appropriate, this reaction sequence can be traversed repeatedly.
Examples of precursors for the biosynthesis of PUFAs are oleic acid, linoleic acid and
linolenic acid. These Cis-carbon fatty acids must be elongated to C20 and C22 in order
to obtain fatty acids of the eicosa and docosa chain type. With the aid of the
desaturases used in the process, such as the ∆ 12-, ∆ 15-, ∆ 12- and ∆ 15-, ω3-, ∆4-,
∆5- and ∆6-desaturases and/or the ∆5-, ∆6-elongases, arachidonic acid,
eicosapentaenoic acid, docosapentaenoic acid or docosahexaenoic acid,
advantageously eicosapentaenoic acid and/or docosahexaenoic acid, can be produced
and subsequently employed in various applications regarding foodstuffs, feedstuffs,
cosmetics o r pharmaceuticals. C20- and/or C22-fatty acids with a t least two,
advantageously at least three, four, five or six, double bonds in the fatty acid molecule,
preferably C20- or C22-fatty acids with advantageously four, five or six double bonds in
the fatty acid molecule, can be prepared using the abovementioned enzymes.
Desaturation may take place before or after elongation of the fatty acid in question.
This is why the products of the desaturase activities and of the further desaturation and
elongation steps which are possible result in preferred PUFAs with a higher degree of
desaturation, including a further elongation from C20- to C22-fatty acids, to fatty acids
such as γ-linolenic acid, dihomo- γ-linolenic acid, arachidonic acid, stearidonic acid,
eicosatetraenoic acid or eicosapentaenoic acid. Substrates of the desaturases and
elongases used in the process according to the invention are C16-, Ciβ- or C2o-fatty
acids such as, for example, linoleic acid, γ-linolenic acid, α-linolenic acid, dihomo- γ-
linolenic acid, eicosatetraenoic acid or stearidonic acid. Preferred substrates are
linoleic acid, γ-linolenic acid and/or α-linolenic acid, dihomo- γ-linolenic acid or
arachidonic acid, eicosatetraenoic acid or eicosapentaenoic acid. The synthesized C20-
or C22-fatty acids with at least two, three, four, five or six double bonds in the fatty acid
are obtained in the process according to the invention in the form of the free fatty acid
or in the form of their esters, for example in the form of their glycerides.
The term "glyceride" is understood as meaning a glycerol esterified with one, two or
three carboxyl radicals (mono-, di- or triglyceride). "Glyceride" is also understood as
meaning a mixture of various glycerides. The glyceride o r glyceride mixture may
comprise further additions, for example free fatty acids, antioxidants, proteins,
carbohydrates, vitamins and/or other substances.
For the purposes of the process according to invention, a "glyceride" is furthermore
understood as meaning glycerol derivatives. In addition to the abovedescribed fatty
acid glycerides, these also include glycerophospholipids and glyceroglycolipids.
Preferred examples which may be mentioned in this context are the
glycerophospholipids such as lecithin (phosphatidylcholine), cardiolipin,
phosphatidylglycerol, phosphatidylserine and alkylacylglycerophospholipids.
Furthermore, fatty acids must subsequently be translocated to various modification
sites and incorporated into the triacylglycerol storage lipid. A further important step in
lipid synthesis is the transfer of fatty acids to the polar head groups, for example by
glycerol fatty acid acyltransferase (see Frentzen, 1998, Lipid, 100(4-5):1 6 1- 166).
Publications on plant fatty acid biosynthesis and on the desaturation, the lipid
metabolism and the membrane transport of lipidic compounds, on beta-oxidation, fatty
acid modification and cofactors, triacylglycerol storage and triacylglycerol assembly,
including the references therein, see the following papers: Kinney, 1997, Genetic
Engineering, Ed.: JK Setlow, 19:149-166; Ohlrogge and Browse, 1995, Plant Cell
7:957-970; Shanklin and Cahoon, 1998, Annu. Rev. Plant Physiol. Plant MoI. Biol.
49:61 1-641 ; Voelker, 1996, Genetic Engineering, Ed.: JK Setlow, 18:1 11-13; Gerhardt,
1992, Prog. Lipid R. 3 1 :397-417; Gϋhnemann-Schafer & Kindl, 1995, Biochim. Biophys
Acta 1256:181-1 86; Kunau et al., 1995, Prog. Lipid Res. 34:267-342; Stymne et al.,
1993, in: Biochemistry and Molecular Biology of Membrane and Storage Lipids of
Plants, Ed.: Murata and Somerville, Rockville, American Society of Plant Physiologists,
150-158, Murphy & Ross 1998, Plant Journal. 13(1):1-16.
The PUFAs produced in the process comprise a group of molecules which higher
animals are no longer capable of synthesizing and must therefore take up, or which
higher animals are no longer capable of synthesizing themselves in sufficient quantities
and must therefore take up additional quantities, although they can be synthesized
readily by other organisms such as bacteria; for example, cats have lost the ability to
synthesize arachidonic acid in the course of evolution.
"Phospholipids" for the purposes of the invention are understood as meaning
phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidyl-
glycerol and/or phosphatidylinositol, advantageously phosphatidylcholine. The terms
"production or productivity" are known in the art and encompass the concentration of
the fermentation product (compounds of the formula I) which is formed within a specific
period of time and in a specific fermentation volume (for example kg of product per
hour per liter). It also comprises the productivity within a plant cell or a plant, that is to
say the content of the desired fatty acids produced in the process relative to the
content of all fatty acids in this cell or plant. The term "production efficiency" comprises
the time required for obtaining a specific production quantity (for example the time
required by the cell to establish a certain throughput rate of a fine chemical). The term
"yield or product/carbon yield" is known in the art and comprises the efficiency of the
conversion of the carbon source into the product (i.e. the fine chemical). This is usually
expressed for example as kg of product per kg of carbon source. By increasing the
yield or production of the compound, the amount of the molecules obtained of this
compound, or of the suitable molecules of this compound obtained, in a specific culture
quantity over a specified period of time is increased. The terms "biosynthesis or
biosynthetic pathway" are known in the art and comprise the synthesis of a compound,
preferably an organic compound, by a cell from intermediates, for example in a multi-
step and strongly regulated process. The terms "catabolism or catabolic pathway" are
known in the art and comprise the cleavage of a compound, preferably of an organic
compound, by a cell to give catabolites (in more general terms, smaller or less complex
molecules), for example in a multi-step and strongly regulated process. The term
"metabolism" is known in the art and comprises the totality of the biochemical reactions
which take place in an organism. The metabolism of a certain compound (for example
the metabolism of a fatty acid) thus comprises the totality of the biosynthetic pathways,
modification pathways and catabolic pathways of this compound in the cell which relate
to this compound.
By employing, in the process according to the invention, the polynucleotides according
to the invention and optionally further polynucleotides which code for enzymes of the
lipid or fatty acid metabolism it is possible to achieve various advantageous effects.
Thus, it is possible to influence the yield, production and/or production efficiency of the
polyunsaturated fatty acids in a plant, preferably in an oil crop plant, or in a
microorganism. The number or activity of the polypeptides or polynucleotides according
to the invention can be increased, so that larger amounts of the gene products and,
ultimately, larger amounts of the compounds of the general formula I are produced. A
de novo synthesis in an organism, which, before the gene(s) in question was/were
introduced, had been lacking the activity and ability to biosynthesize the compounds, is
also possible. The same applies analogously to the combination with further
desaturases or elongases or further enzymes of the fatty acid and lipid metabolism.
The use of a variety of divergent sequences, i.e. sequences which differ at the DNA
sequence level, may also be advantageous in this context, or else the use of gene
expression promoters which makes possible a different gene expression as far as
timing is concerned, for example as a function of the degree of maturity of a seed or oil-
storing tissue.
By introducing, into an organism, a polynucleotide according to the invention alone or
in combination with other genes in a cell it is possible not only to increase the
biosynthetic flow towards the end product, but also to increase, or to create de novo,
the corresponding triacylglycerol composition. Equally, the number or activity of other
genes which are required for the import of nutrients for the biosynthesis of one or more
fatty acids, oils, polar and/or neutral lipids can be increased, so that the concentration
of these precursors, cofactors or intermediates within the cells or within the storage
compartment is increased, whereby the ability of the cells to produce PUFAs is further
enhanced. By optimizing the activity, or increasing the number, of one or more
polynucleotides or polypeptides according to the invention which are involved in the
biosynthesis of these compounds, or by destroying the activity of one or more genes
which are involved in the degradation of these compounds, it may be possible to
increase the yield, production and/or production efficiency of fatty acid and lipid
molecules from organisms, in particular from plants. The fatty acids obtained in the
process are suitable as starting materials for the chemical synthesis of further products
of interest. For example, they can be used for the preparation of pharmaceuticals,
foodstuffs, animal feeds or cosmetics, either alone or in combination with one another.
It can be seen from what has been said above that the invention also relates to a
process for the preparation of an oil, lipid or fatty acid composition, comprising the
steps of the process according to the invention and the further step of formulating the
substance as an oil, lipid or fatty acid composition.
In a preferred embodiment of this process, the oil, lipid or fatty acid composition is
formulated further to give a drug, a cosmetic product, a foodstuff, a feedstuff, preferably
fish food, or a food supplement.
Finally, the invention relates to the principle of using the polynucleotide, the vector, the
host cell, the polypeptide or the transgenic, nonhuman organism of the present
invention for the production of an oil, lipid or fatty acid composition. The latter should
then preferably be employed as drug, cosmetic product, foodstuff, feedstuff, preferably
fish food, or food supplement.
The content of all the references, patent applications, patents and published patent
applications cited in the present patent application is hereby incorporated by reference
to the respective specific disclosure.
Figures
Figure 1: Biosynthetic pathways for the production of long-chain, polyunsaturated fatty
acids such as arachidonic acid (= ARA, C20:4∆5A11 M ) , eicosapentaenoic acid (= EPA,
C20:5∆5 8 1 1 14 7) or docosahexaenoic acid (= DHA, C22:6∆4 10 13 16 9) .
Figure 2 : Gas-chromatographic determination of the fatty acids from yeasts which have
been transformed with the plasmid pYES (A) or pYES-d1 5Des(Ch) (B) and pYES-
d 15Des(Cy) (C), respectively.
Examples
Example 1: General cloning methods
The cloning methods such as, for example, restriction cleavages, agarose gel
electrophoresis, purification of DNA fragments, transfer of nucleic acids to
nitrocellulose and nylon membranes, linkage of DNA fragments, transformation of
Escherichia coli cells, bacterial cultures and the sequence analysis of recombinant
DNA were carried out as described by Sambrook et al. ( 1989) (Cold Spring Harbor
Laboratory Press: ISBN 0-87969-309-6).
Example 2 : Sequence analysis of recombinant DNA
Recombinant DNA molecules were sequenced with an ABI laser fluorescence DNA
sequencer by the method of Sanger (Sanger et al. ( 1977) Proc. Natl. Acad. Sci.
USA74, 5463-5467). Fragments obtained by polymerase chain reaction were
sequenced and verified to avoid polymerase errors in constructs to be expressed.
Example 3 : Lipid extraction from yeasts
The effect of the genetic modification in plants, fungi, algae, ciliates or on the
production of a desired compound (such as a fatty acid) can be determined by growing
the modified microorganisms or the modified plant under suitable conditions (such as
those described above) and analyzing the medium and/or the cellular components for
the elevated production of the desired product (i.e. of lipids or a fatty acid). These
analytical techniques are known to the skilled worker and comprise spectroscopy, thin-
layer chromatography, various types of staining methods, enzymatic and
microbiological methods and analytical chromatography such as high-performance
liquid chromatography (see, for example, Ullman, Encyclopedia of Industrial Chemistry,
Vol. A2, p. 89-90 and p. 443-61 3 , VCH: Weinheim ( 1985); Fallon, A., et al., ( 1987)
"Applications of HPLC in Biochemistry" in: Laboratory Techniques in Biochemistry and
Molecular Biology, Vol. 17 ; Rehm et al. ( 1993) Biotechnology, Vol. 3 , Chapter III:
"Product recovery and purification", p. 469-714, VCH: Weinheim; Belter, P.A., et al.
(1988) Bioseparations: downstream processing for Biotechnology, John Wiley and
Sons; Kennedy, J.F., and Cabral, J.M.S. ( 1992) Recovery processes for biological
Materials, John Wiley and Sons; Shaeiwitz, J.A., and Henry, J.D. ( 1988) Biochemical
Separations, in: Ullmann's Encyclopedia of Industrial Chemistry, Vol. B3; Chapter 11,
p . 1-27, VCH: Weinheim; and Dechow, F.J. (1989) Separation and purification
techniques in biotechnology, Noyes Publications).
In addition to the abovementioned processes, plant lipids are extracted from plant
material as described by Cahoon et al. ( 1999) Proc. Natl. Acad. Sci. USA 96
(22): 12935-1 2940 and Browse et al. (1986) Analytic Biochemistry 152:141-145. The
qualitative and quantitative analysis of lipids or fatty acids is described in Christie,
William W., Advances in Lipid Methodology, Ayr/Scotland: Oily Press (Oily Press Lipid
Library; 2); Christie, William W., Gas Chromatography and Lipids. A Practical Guide -
Ayr, Scotland: Oily Press, 1989, Repr. 1992, IX, 307 pp. (Oily Press Lipid Library; 1);
"Progress in Lipid Research", Oxford: Pergamon Press, 1 (1952) - 16 (1977) under the
title: Progress in the Chemistry of Fats and Other Lipids CODEN.
In addition to measuring the end product of the fermentation, it is also possible to
analyze other components of the metabolic pathways which are used for the production
of the desired compound, such as intermediates and by-products, in order to determine
the overall production efficiency of the compound. The analytical methods comprise
measuring the amount of nutrients in the medium (for example sugars, hydrocarbons,
nitrogen sources, phosphate and other ions), measuring the biomass composition and
the growth, analyzing the production of conventional metabolites of biosynthetic
pathways and measuring gases which are generated during the fermentation. Standard
methods for these measurements are described in Applied Microbial Physiology; A
Practical Approach, P.M. Rhodes and P.F. Stanbury, Ed., IRL Press, p. 103-129;
131-163 and 165-192 (ISBN: 0199635773) and references cited therein.
One example is the analysis of fatty acids (abbreviations: FAME, fatty acid methyl
ester; GC-MS, gas liquid chromatography/mass spectrometry; TAG, triacylglycerol;
TLC, thin-layer chromatography).
Unambiguous proof for the presence of fatty acid products can be obtained by
analyzing recombinant organisms using standard analytical methods: GC, GC-MS or
TLC, as described on several occasions by Christie and the references therein (1997,
in: Advances on Lipid Methodology, Fourth Edition: Christie, Oily Press, Dundee,
119-169; 1998, Gaschromatographie-Massenspektrometrie-Verfahren [Gas
chromatography/mass spectrometry methods], Lipide 33:343-353).
The material to be analyzed can be disrupted by sonication, grinding in a glass mill,
liquid nitrogen and grinding or via other applicable methods. After disruption, the
material must be centrifuged. The sediment is resuspended in distilled water, heated
for 10 minutes at 100 C, cooled on ice and recentrifuged, followed by extraction for one
hour at 90 C in 0.5 M sulfuric acid in methanol with 2% dimethoxypropane, which leads
to hydrolyzed oil and lipid compounds, which give transmethylated lipids. These fatty
acid methyl esters are extracted in petroleum ether and finally subjected to a GC
analysis using a capillary column (Chrompack, WCOT Fused Silica, CP-Wax-52 CB,
25 micrometer, 0.32 mm) at a temperature gradient of between 170 C and 240 C for
20 minutes and 5 minutes at 240 C. The identity of the resulting fatty acid methyl
esters must be defined using standards which are available from commercial sources
(i.e. Sigma).
Example 4 : Cloning desaturase genes
The fungus Mycocentrospora acerina was grown for five days at 25°C in 50 ml of liquid
medium (3 g/l yeast extract, 3 g/l malt extract, 3 g/l peptone, 10 g/l glucose, 0.68 g/l
K2HPO4 pH 6.0) on a shaker at 200 rpm. After the cells were harvested by
centrifugation at 2000 x g , 5 min, 4°C, 2 g of cell pellet were obtained. The pellet was
washed 3x with distilled water. Total-RNA was isolated using the RNeasy plant mini Kit
(Quiagen, Hilden, Germany) in accordance with the manufacturer's instructions. This
RNA was employed in order to obtain "5'RACE-ready" and "3'-RACE ready" cDNA
using the SMART RACE cDNA Amplification Kit (Clontech, Heidelberg, Germany),
following the manufacturer's instructions. To isolate novel desaturase genes, the
following degenerate primers were employed in combination with the "5'-RACE ready"
cDNA:
Deg.1 (SEQ ID No.: 42):
5'-TGGGTI (CZT)T(TZCZG)GCICA(CZT)GA(AZG)TG(CZT)GG(AZTZC)CA-S'
Deg.2 (SEQ ID No.: 43):
5'-TTIGG(AZG)TCIGT(AZG)TG(CZT)TG(AZCZG)A(AZG)(AZG)AAIGT-S'
The following PCR protocol was employed for the amplification:
a) 2 min at 95°C,
b) 30 sec at 940C
30 sec at 55-72°C
2 min at 720C
Number of cycles: 30
c) 10 min at 720C
PCR amplificates were sequenced after having been cloned into pCR2.1-TOPO
(Invitrogen, Karlsruhe, Germany) following the manufacturer's instructions. One
sequence showed homology to known ∆-12 and ∆-15 desaturases (Sayanova O et al.
J. Biol. Chem., 2006, 281, 36533-36541) in the ClustalW alignment (Thompson JD, et
al., Nucleic Acids Res., 1994, 22: 4673-4680). This known sequence section was
extended at both ends (5' and 3') by Rapid Amplification of cDNA Ends (RACE) by
means of the SMART RACE cDNA Amplification Kit (Clontech, Heidelberg, Germany).
To this end, the following sequence-specific primers were derived in the known
sequence region:
5RACE1 (SEQ ID No.: 44): '-ATGAAGACCATGTCGCGCTCCATGT-S'
3RACE1 (SEQ ID No.: 45): '-GACGAGCACCTCATCCTGCTTAG-S'
These primers in combination with the "5'-RACE ready" or "3'-RACE ready" cDNA of
the fungus Mycocentrospora acerin gave the complete mRNA sequence (SEQ ID
No.:15, Table 1).
For the other candidate sequences listed, complete genomic sequences were identified
in a first step, in accordance with database entries. In a further step, the coding
sequence was extracted with the aid of methods of bioinformatics. In order to obtain
the corresponding coding sequence from the organisms, these can be amplified in a
PCR reaction from cDNA preparations, using the primer sequences defined in Table 1.
This may give rise to fragments as are described in Table 2 .
By searching for conserved regions in the protein sequences, derived from the DNA, of
the organisms Cochliobolus heterostrophus C5, Cyanothece sp. CCY01 10 and
Mycocentrospora acerina, it was possible to identify sequences with putative ∆ 12-
desaturase activity or ∆ 15-desaturase activity. In particular when a succession of the
desaturase motif 1 "GX10HX3HX13GX9PX3WX3H" (SEQ ID No: 46), the desaturase motif
2 "PXi 4(H/Q)H" (SEQ ID No: 47) and either the desaturase motif 3 "HX2HHX5PXY"
(SEQ ID No: 48) or the desaturase motif 4 "HX2HHX6PXY" (SEQ ID No: 49) are found
in the sequence, this is indicative of ∆ 12-desaturases or ∆ 15-desaturases, where X
stands for any amino acid. Whether it is a putative ∆ 12-, ∆ 15- or omega3-desaturase
can be deduced from the amino acid at the variable position 16 of the desaturase motif
2 (H or Q): Q = glutamine is indicative of putative ∆ 12-desaturases, H = histidine is
indicative of putative ∆ 15- or omega3-desaturases.
Table 1: Primer sequences for cloning the desaturases which have been identified.
Table 2 : Coding polynucleotide or amino acid sequences of the desaturases which
have been identified.
Table 3 : Genomic sequences (gDNA) or transcript sequences (mRNA) of the
desaturases which have been identified.
To characterize the functions of the individual sequences, the open reading frame of
the DNA (Table 2) is cloned downstream of the galactose-inducible GAL1 promoter of
pYES2.1/V5-His-TOPO (Invitrogen), giving rise to the plasmids pYES-D15Des(Ch),
pYES-D15Des(Cy) or pYes-D12Des(Mac). Then, following manufacturer's instructions,
these plasmids can then be transformed into the yeast strain INVSC-1 (Invitrogen) and
selected for uracil auxotrophism on plates with DOB-U agar. Positive colonies are
identified by PCR. To this end, PCR is carried out in each case with 1 µl of defrosted
cells, 200 µM dNTPs, 2.5 U Tag-polymerase and 100 pmol of each primer in a total
volume of 50 µl . The PCR conditions are as follows: first denaturation at 95°C for 5
minutes, followed by 30 cycles at 94°C for 30 seconds, 55°C for 1 minute and 72°C for
2 minutes, and a last elongation step at 72°C for 10 minutes. In parallel, the empty
vector pYES2.1/V5-His-TOPO is transformed in the above-described manner into
competent yeast cells of strain INVSC-1 . Yeast cells with the plasmids pYES-
D 15Des(Ch), pYES-D15Des(Cy) or pYes-D12Des(Mac) are incubated for 12 h in liquid
DOB-U medium at 280C and 200 rpm and then grown for a further 12 h in induction
medium (DOB-U+2% (w/v) galactose+2% (w/v) raffinose) and 250 µM of fatty acids
which are added into the medium. The specificity and activity of the gene to be
characterized can be determined with reference to the added fatty acids.
Yeasts transformed with the plasmids pYES2/V5-His-TOPO or pYES-D15Des(Ch),
pYES-D15Des(Cy) or pYes-D12Des(Mac) are analyzed as follows:
The yeast cells from the main cultures are harvested by centrifugation (100 x g , 5 min,
200C) and washed with 100 mM NaHCO3, pH 8.0 to remove residual medium and fatty
acids. Starting with the yeast cell sediments, fatty acid methyl esters (FAMEs) are
prepared by acid methanolysis. To this end, the cell sediments are incubated for one
hour at 800C together with 2 ml of 1 N methanolic sulfuric acid and 2% (v/v) of
dimethoxypropane. The FAMEs are extracted twice with petroleum ether (PE). To
remove nonderivatized fatty acids, the organic phases are washed in each case once
with 2 ml of 100 mM NaHCO 3, pH 8.0 and 2 ml of distilled water. Thereafter, the PE
phases are dried with Na2SO4, evaporated under argon and taken up in 100 µl of PE.
The samples are separated on a DB-23 capillary column (30 m, 0.25 mm, 0.25 µm,
Agilent) in a Hewlett-Packard 6850 gas chromatograph equipped with flame ionization
detector. The conditions for the GLC analysis are as follows: the oven temperature was
programmed from 500C to 250°C with an increment of 5°C/min and finally 10 min at
250 0C (holding).
The signals are identified by comparing the retention times with corresponding fatty
acid standards (Sigma). The methodology is described for example in Napier and
Michaelson, 2001 , Lipids. 36(8):761-766; Sayanova et al., 2001 , Journal of
Experimental Botany. 52(360):1 581 -1585, Sperling et al., 2001 , Arch. Biochem.
Biophys. 388(2):293-298 and Michaelson et al., 1998, FEBS Letters. 439(3):215-218.
Activity and substrate determination of the desaturases which have been identified
The substrate specificity of D15Des(Ch) or D15Des(Cy) can be determined after
expression and after the feeding of various fatty acids. Departing from the conserved
desaturase motif 2 (SEQ ID No. 47), the following activity was found for the coding
sequences (Table 4).
Table 4 : Activity of the desaturases which have been identified
These activities which have been found were additionally verified by expressing the
desaturases in yeast. Table 4A lists the conversion of various fatty acid substrates into
the expected fatty acid products. Except for the fatty acid 18:1n-9, all substrates were
fed in the experiment and are therefore present in excess. Figure 2 shows the














By way of control for the assay for ∆ 15-desaturase activity, yeasts were transformed
with the pYES empty vector, the fatty acid 18:2n-6 was fed, and the fatty acid profile
was analyzed (Figure 2A). In comparison, the additional fatty acid 18:3n-3 can be
observed in yeasts which express the desaturases d15Des(Ch) and d15Des(Cy)
(Figure 2B, 2C). These desaturases which have been assayed therefore have ∆ 15-
desaturase activity.
Example 5 : Production of transgenic plants for the production of long-chain
polyunsaturated fatty acids
To produce long-chain polyunsaturated fatty acids in plants, various genes of the
metabolic pathway are combined on a binary vector. To produce the fatty acid
eicosapentaenoic acid (20:5∆5 ,8 ,11,14,17), genes as described in Table 5 are
combined. Analogously, the genes as described in Table 6 are combined for producing
the fatty acid docosahexaenoic acid (22:6∆4,7,10,13,16,19).
Table 5 : Gene combination for the production of eicosapentaenoic acid
Table 6 : Gene combination for the production of docosahexaenoic acid
Further transformation vectors based on pSUN-USP were generated for the
transformation of plants. To this end, Notl cleavage sites were introduced at the 5' and
at the 3' end of the coding sequence, using the following primer pairs (see Table 7).
Composition of the PCR mix (50 µl):
5.00 µl template cDNA
5.00 µl 10x buffer (Advantage polymerase) + 25mM MgCb
5.00 µl 2mM dNTP
1.25 µl of each primer (10 pmol/µL)
0.50 µl Advantage polymerase
The Advantage polymerase from Clontech is employed.
PCR reaction conditions:
Annealing temperature: 1 min 550C
Denaturation temperature: 1 min 940C
Elongation temperature: 2 min 720C
Number of cycles: 35
Table 7 : Primer sequences (for cloning transformation vectors based on pSUN-USP)
The PCR products are incubated with the restriction enzyme Notl for 4 h at 37°C. The
plant expression vector pSUN300-USP is incubated in the same manner. Thereafter,
the PCR products and the 7624 bp vector are separated by agarose gel
electrophoresis, and the corresponding DNA fragments are excised. The DNA is
purified by means of the Qiagen gel purification kit, following the manufacturer's
instructions. Thereafter, vector and PCR products are ligated. The Rapid Ligation kit
from Roche is used for this purpose. The plasmids generated are verified by
sequencing.
pSUN300 is a derivative of the plasmid pPZP (Hajdukiewicz, P, Svab, Z , Maliga, P.,
( 1994) The small versatile pPZP family of Agrobacterium binary vectors for plant
transformation. Plant MoI Biol 25:989-994). pSUN-USP originated from pSUN300, by
inserting a USP promoter into pSUN300 in the form of an EcoRI fragment. The
polyadenylation signal is the OCS gene from the A . tumefaciens Ti plasmid (ocs-
Terminator, Genbank Accession V00088) (De Greve, H., Dhaese, P., Seurinck, J.,
Lemmers, M., Van Montagu, M. and Schell, J. Nucleotide sequence and transcript map
of the Agrobacterium tumefaciens Ti plasmid-encoded octopine synthase gene J. MoI.
Appl. Genet. 1 (6), 499-51 1 (1982). The USP promoter corresponds to nucleotides 1 to
684 (Genbank Accession X56240), where part of the noncoding region of the USP
gene is present in the promoter. The promoter fragment which is 684 base pairs in size
was amplified by a PCR reaction using standard methods with the aid of a synthesized
primer and by means of a commercially available T7 standard primer (Stratagene)
(Primer sequence:
5'-GTCGACCCGCGGACTAGTGGGCCCTCTAGACCCGGGGGATCC
GGATCTGCTGGCTATGAA-3') [SEQ ID NR: 82].
The PCR fragment was recut with EcoRI/Sall and inserted into the vector pSUN300
with OCS terminator. This gave rise to the plasmid named pSUN-USP, which can be
employed for transforming plants by means of Agrobacterium tumefaciens.
a) Generation of transgenic oilseed rape plants (modified method of Moloney et al.,
1992, Plant Cell Reports, 8:238-242)
To generate transgenic oilseed rape plants, binary vectors such as the pSUN plasmids
described hereinabove are transformed into Agrobacterium tumefaciens
C58C1 :pGV2260 (Deblaere et al, 1984, Nucl. Acids. Res. 13 , 4777-4788). A 1:50
dilution of an overnight culture of a positively transformed agrobacterial colony in
Murashige-Skoog medium (Murashige and Skoog 1962 Physiol. Plant. 15 , 473)
supplemented with 3% sucrose (3MS medium) is used for transforming oilseed rape
plants (cv. Westar). Petioles or hypocotyls of freshly germinated sterile oilseed rape
plants (in each case approx. 1 cm2) are incubated with a 1:50 agrobacterial dilution for
5-10 minutes in a Petri dish. This is followed by 3 days of coincubation in the dark at
25°C on 3MS medium supplemented with 0.8% Bacto agar. After 3 days, the cultivation
is continued with 16 hours light/8 hours dark and is continued, in a 1-week rhythm, on
MS medium supplemented with 500 mg/l Claforan (cefotaxim-sodium), 50 mg/l
kanamycin, 20 µM benzylaminopurine (BAP) and 1.6 g/l glucose. Growing shoots are
transferred to MS medium supplemented with 2% sucrose, 250 mg/l Claforan and 0.8%
Bacto agar. If no roots have formed after three weeks, the growth hormone
2-indolebutyric acid is added to the medium to promote rooting.
Regenerated shoots are obtained on 2MS medium supplemented with kanamycin and
Claforan, transferred into soil once rooted, and after cultivation for two weeks grown in
a controlled-environment cabinet or in a greenhouse, flowering is induced, mature
seeds are harvested and analyzed for expression of the desaturase or elongase genes
by means of lipid analyses as described by way of example in Qiu et al. 2001 , J. Biol.
Chem. 276, 31561-31566.
b) Generation of transgenic linseed plants
Transgenic linseed plants can be generated for example by the method of Bell et al.,
1999, In Vitro Cell. Dev. Biol.-Plant. 35(6):456-465 by means of particle bombardment.
Agrobacterial-mediated transformations can be effected for example as described by
Mlynarova et al. (1994), Plant Cell Report 13: 282-285.
We claim:
1. A polynucleotide comprising a nucleic acid sequence selected from the group
consisting of:
(a) nucleic acid sequence as shown in SEQ ID NO. 1, 2 , 8 , 9 , 15, 16, 50 and
5 1 ;
(b) nucleic acid sequence which codes for a polypeptide which features an
amino acid sequence as shown in any of SEQ ID NO. 3 , 10, 17 and 52;
(c) nucleic acid sequence which has at least 70% identity to one of the
nucleic acid sequences of (a) or (b), and which codes for a polypeptide
with a desaturase activity; and
(d) nucleic acid sequence for a fragment of a nucleic acid of (a), (b) or (c),
wherein the fragment codes for a polypeptide with desaturase activity.
2 . The polynucleotide according to claim 1, wherein the polynucleotide consists of
RNA or DNA.
3 . A vector comprising the polynucleotide according to claim 1 or 2 .
4 . The vector according to claim 3 , wherein the vector is an expression vector.
5 . The vector according to claim 3 or 4 , wherein the vector comprises at least one
further polynucleotide which codes for a further enzyme which is involved in the
biosynthesis of lipids or fatty acids.
6 . A host cell comprising the polynucleotide according to claim 1 or 2 or the vector
according to any of claims 3 to 5 .
7 . The host cell according to claim 6 , wherein the host cell additionally comprises at
least one further enzyme which is involved in the biosynthesis of lipids or fatty
acids.
8 . The vector according to claim 5 or the host cell according to claim 7 , wherein the
enzyme is selected from the group consisting of: acyl-CoA dehydrogenase(s),
acyl-ACP [= acyl carrier protein] desaturase(s), acyl-ACP thioesterase(s), fatty
acid acyltransferase(s), acyl-CoA:lysophospholipid acyltransferase(s), fatty acid
synthase(s), fatty acid hydroxylase(s), acetyl-coenzyme A carboxylase(s), acyl-
coenzyme A oxidase(s), fatty acid desaturase(s), fatty acid acetylenase(s),
lipoxygenase(s), triacylglycerol lipase(s), allene oxide synthase(s), hydroperoxide
lyase(s), fatty acid elongase(s), ∆ 4-desaturase(s), ∆5-desaturase(s), ∆6-
desaturase(s), ∆δ-desaturase(s), ∆9-desaturase(s), ∆ 12-desaturase(s),
∆5-elongase(s), ∆θ-elongase(s) and ∆9-elongase(s).
9 . A method of generating a polypeptide with desaturase or elongase activity,
comprising the steps:
(a) expressing a polynucleotide according to claim 1 or 2 in a host cell; and
(b) obtaining, from the host cell, the polypeptide which is encoded by the
polynucleotide according to (a).
10 . A polypeptide which is encoded by the polynucleotide according to claim 1 or 2 or
which is obtainable by the method according to claim 9 .
11. An antibody which specifically recognizes the polypeptide according to claim 10.
12. A transgenic, nonhuman organism comprising the polynucleotide according to
claim 1 or 2 , the vector according to any of claims 3 to 5 or the host cell
according to claim 6 or 7 .
13. The transgenic, nonhuman organism according to claim 12 , wherein the
organism is an animal, a plant or a multicellular microorganism.
14. A process for the production of a substance which has the structure shown in the
general formula I hereinbelow
wherein the variables and substituents are as follows:
R1 = hydroxyl, coenzyme A (thioester), lysophosphatidylcholine,
lysophosphatidylethanolamine, lysophosphatidylglycerol,
lysodiphosphatidylglycerol, lysophosphatidylserine,
lysophosphatidylinositol, sphingo base or a radical of the formula
R2 = hydrogen, phosphatidylcholine, phosphatidylethanolamine,
phosphatidylglycerol, diphosphatidylglycerol, phosphatidylserine,
phosphatidylinositol or saturated or unsaturated C 2 toC24-alkylcarbonyl,
R3 = hydrogen, a saturated or unsaturated C 2 to C24-alkylcarbonyl, or R2 and
R3 independently of one another are a radical of the formula Ia:
n = 2 , 3 , 4 , 5 , 6 , 7 or 9 , m = 2 , 3 , 4 , 5 or 6 and p = 0 or 3 ;
and
wherein the process comprises the cultivation of (i) a host cell according to any
of claims 3 to 5 or (ii) of a transgenic, nonhuman organism according to claim 12
or 13 under conditions which permit the biosynthesis of the substance.
15. A process for the production of an oil, lipid or fatty acid composition, comprising
the steps of the process according to claim 14 and the further step of formulating
the substance as an oil, lipid or fatty acid composition.
16. The process according to claim 15, wherein the oil, lipid or fatty acid composition
is formulated further to give a drug, a cosmetic product, a foodstuff, a feedstuff,
preferably fish food, or a food supplement.
17 . The use of the polynucleotide according to claim 1 or 2 , of the vector according to
any of claims 3 to 5 , of the host cell according to claim 6 or 7 , of the vector or the
host cell according to claim 8 , of the polypeptide according to claim 10 or of the
transgenic, nonhuman organism according to claim 12 or 13 for the production of
an oil, lipid or fatty acid composition.
18. The use according to claim 17, wherein the oil, lipid or fatty acid composition is to
be employed as a drug, cosmetic product, foodstuff, feedstuff, preferably fish
food, or food supplement.
